2012

201212

--2012-68

2012

201212

KOREA HEALTH INDUSTRY DEVELOPMENT INSTITUTE

2012 () .

2012 12

: : (, ) : (, ) (, ) (, )

2012

/ 1 1 / 111. 11 2. 14

2 / 221. 22 2. 29

3 / 531. 53 2. 72 3. 82

4 / 971. 97 2. 4 99 3. 102 4. 107

5 / 108 111 : 113

i

2012

1 2 1-1 1-2 1-3 1-4 1-5 1-6 2-1 2-2 2-3 2-4 2-5 2-6 2-7 2-8 2-9

5 5 15 16 17 18 19 21 (20062011) 23 (20062011) 24 (20112017) 25 2011 26 (20062011) 27 (20062011) 28 29 (20072011) 30 (20072011) 31

2-10 (20122017) 31 2-11 (20072011) 32 2-12 (20072011) 33 2-13 (2011) 33 2-14 5 (2011) 34 2-15 35 2-16 (20072011) 36 2-17 (20072011) 37 2-18 (20122017) 37 2-19 (20072011) 38

ii

2-20 (20072011) 39 2-21 (2011) 39 2-22 5 (2011) 40 2-23 41 2-24 (20072011) 42 2-25 (20072011) 43 2-26 (20122017) 43 2-27 (20072011) 44 2-28 (20072011) 45 2-29 (2011) 45 2-30 5 (2011) 46 2-31 47 2-32 (20072011) 48 2-33 (20072011) 49 2-34 (20122017) 49 2-35 (20072011) 50 2-36 (20072011) 51 2-37 (2011) 51 2-38 5 (2011) 52 3-1 3-2 3-3 3-4 3-5 3-6 3-7 3-8 3-9 54 55 55 56 1 57 58 59 (14) 60 61

3-10 2011 30 62 3-11 2011 20 63 3-12 (2011) 64 3-13 (2011) 65iii

3-14 (14) 67 3-15 68 3-16 69 3-17 2011 30 70 3-18 2011 20 71 3-19 4 72 3-20 4 73 3-21 2011 10 75 3-22 2011 EU 10 77 3-23 2011 10 79 3-24 2011 10 81 3-25 84 3-26 85 3-27 86 3-28 87 3-29 88 3-30 89 3-31 90 3-32 EBIT 91 3-33 92 3-34 93 3-35 94 3-36 95 3-37 96 4-1 4-2 4-3 4-4 4-5 4-6 4-7 4 98 10 4 101 10 102 10 104 10 (2011) 105 10 106 10 (2011) 107

iv

2012

2-1 23 3-1 ( ) 53 3-2 66 3-3 74 3-4 EU 76 3-5 78 3-6 80 4-1 10 4 100 4-2 10 103 4-3 10 (20072011) 103 4-4 10 (20102011) 105

v

3

1. , . , , , . . , , , .

2. 2011 2,988 (Espicom, 2012), 2010 9.7% . 2006 2011 7.9% . 2011 / 1,341(44.9%) , 2006 7.7% . , , 644(21.5%) 6.6% , , , / 605(20.3%) 10.8% . 2017 4,344 , 2012

4 2012

6.4% . , , , . 2011 1,154 38.6%, 20 87.4% . 305(10.2%), 241 (8.1%), 135(4.5%), 115(3.8%) . 2011 13(39) 1.3% .

3. ( ) 2011 4 3,064 2010 3 9,027 10.3% . 2006 2011 8.3% . 2011 3 3,665 2010 2 9,644 13.6% . 2006 2011 11.5% . 2006 2011 18.9% , 2011 1 8,538 2010 10.2% . 2011 2010 6.6% 2 7,937, 2006 2011 10.2%. 2011 9,399 0.2% . 2011 64.9% 2.3%p . , 2011 . 2006 6067% .

5

1 ( : , %) 2006 2007 2008 2009 2010 2011 (0611)

1,949,159 (14.4) 781,043 (9.1) 1,719,323 (11.2) -938,280 (13.0) 2,887,438 (13.9) 59.5

2,216,965 (13.7) 959,094 (22.8) 2,001,423 (16.4) -1,042,329 (11.1) 3,259,294 (12.9) 61.4

2,525,203 (13.9) 1,248,138 (30.1) 2,340,883 (17.0) -1,092,745 (4.8) 3,617,947 (11.0) 64.7

2,764,261 (9.5) 1,519,027 (21.7) 2,398,814 (2.5) -879,787 (19.5) 3,644,047 (0.7) 65.8

2,964,445 (7.2) 1,681,619 (10.7) 2,619,895 (9.2) -938,276 (6.6) 3,902,720 (7.1) 67.1

3,366,462 (13.6) 1,853,785 (10.2) 2,793,709 (6.6) -939,925 (0.2) 4,306,387 (10.3) 64.9

11.5 18.9 10.2 8.3 -

: 1. ( ) 2. -+, / 3. : , ,

2011 32,255, 17,712 . 6.8% , 2008 2010 9.8%, 2011 2.9% . 2005 2011 3.9%, 6.0% . 2 ( : , %) 2005 2006 2007 2008 2009 2010 2011 (0511)

25,610 (1.3) 12,469 (1.9)

26,399 ( 3.1) 14,634 (17.4)

26,936 ( 2.0) 17,429 (19.1)

27,527 (2.2) 16,866 (3.2)

28,167 (2.3) 15,677 (7.0)

30,190 (7.2) 17,219 (9.8)

32,255 (6.8) 17,712 (2.9)

3.9 6.0

: , ( ) : , ,

6 2012

2011 , 2011 (1,423) 4 3,317( 2 1,917, 2 1,399), (1,195) 5 7,124 . 2011 5 5,882 9.6% , 2007 13.0% . . 2011 142 7.9% 0.4%p . 2008 . (2012) 4.5%, 5.6% .

4. 10 /, /, / , . 10 2011 6.8% , 5.1% . 10 2011 1,341.2 2009 . 10 7.5%p , . 2011 18.6%, 10 11.1% . 2011 Johnson & Johnson(MD&D) 17.5 67, 10 27 . 10 1.5%p . 2007 . , , .

7

5. , . , . , 8.5 (9,399) . . 2007 3.2 13.0% 2011 5.6 . , , 2007 . , , , . , . 2007 , . , , .

1 11

1

1. 1) , ( 2). .

1. 2. 3. 4.

, 65 ()() 1).

1) , (, , (), 2009

12 2012

. , , , (inter-disciplinary) ( , 2009). (GHTF2) : Global Harmonization Task Force) , , , , , , , , .

- , , , - , , , - , - - () - -

, .

2) , , . , . , , MRI, CT, , 2) (GHTF : Global Harmonization Task Force) :

1 13

. , . , 10 . , . , . . , , , . . FDA 7.2, 13. . , . . , . . , . , . / 35 . .

14 2012

2. / . , . / , .

1) .

, , , . (A) (Medical Instruments) (B) (Medical supplies) (C) (Dental Materials), (D) . 130 2,191, 5 . 4 , .

1) 2) 3) 4) 5) ( )

1 . 24 .

1 15

1-1

1 2 3 4

, , / , / , CT, MRI ,

IT . (2012) , 69 .

.

27 16 , 207 , 1,648 . LC. . LC04 /, LC05 //, LC14 . LC07 , LC10 .

16 2012

1-2

LC0401. / LC0402. / LC04 / LC0403. LC0404. LC0405. LC0406. LC0407. LC0501. LC0502. LC0503. LC0504. LC0505. LC0506. LC1401. LC1402. LC14

LC0408. LC0409. LC0410. X-ray/CT LC0411. MRI LC0412. / LC0499. / LC0507. LC0508. / LC0509. / LC0599. //

LC05 //

LC1403. / LC1404. LC1405. / LC1499.

LC07 LC10

LC0704. LC0705. LC1012.

. ()

3). .3) 2010-71(2010.4.1),

1 17

, , , , , , 7 . / / 6 . . 1-3

(16)

, , , , , , , , / , , , X-ray CT, MRI, , , , , , , , , , , / , /

/ (10)

: 2010-71(2010.4.1),

2) .

(, ) (). 21 , 76 , 228 , 387 , 1,145 . C , G . , , .

18 2012

1-4 (KSIC-9)

2 2-1 2-1-1 2-1-2 2-1-3 2-1-4 2-1-5 2-1-6 2-1-7 2-1-8 2-1-9 2-2 2-2-1 2-2-2 2-3 2-3-1 2-3-2

C27 C271

, ,

C27111 C27112 C27191 C27192 C27193 C27199 C27310 C27321

C21300 G4644 G4659 ,

G46442 G46592 , G4781 , ,

G47812 G47822

1 19

. (16 )

, , 16 . 1-5

X : CT(), (Digital) X-ray system 1 MRI(), PET(), , , , , PACS ( , , ), , Patient Monitor(), , , 2 , , ( ) (, ), , (, , ), , , , , , , , /, , 4 , , , , , , , (, , ), , , , /, 6 (active) / , / , , , , , , , , , 7 (non-active) () , , , , , , , ,

3

5

8

(, ), (, , , , ), , , , , , , , , , , ,

9

20 2012

10

, , , , , , , , , , , , , , , , / , , , ,

11

12

, , , , , , , , , , , , , , , , , (, ), , , // /

13

14

15

16

. ,

, , 5 4). , , , 80%, 15% 5% . Espicom 5 (Diagnostic imaging), (Dental

products), (Orthopaedic & implantable), (Consumables), (others) .

4) 5 (2010),

1 21

1-6

X-ray, CT, MRI, DR , , , , , , , , , , , , , ,

GE, , , , Hitachi,

, , , , , , , , , , , , , , , , , , LG CNS

Densply, Danaher, Nobel Biocare, 3M Healthcare , Zimmer, Depuy, Stryker , , Medtronics, Carolon, Chemilens Accuray, ConMed, OttoBock, OG Giken, GE, Agfa

: 5 (2010),

22 2012

2

1. 1) 2011 2,988 (Espicom, 2012), 2010 9.7% . 2006 2,041 2008 2,541 11% 2009 , 2006 2011 7.9% .

2 23

2-1 : Espicom

2011 / 1,341(44.9%) , 2006 7.7% . , , 644(21.5%) 6.6% , , , / 605(20.3%) 10.8% . 2-1 (20062011)( : , %)2011 2006 2007 2008 2009 2010 (0611)

/ / / : Espicom(2012)

927 363 468 214 68 2,041

1,035 387 544 252 75 2,293

1,116 437 609 294 85 2,541

1,057 445 597 252 86 2,437

1,219 530 612 269 94 2,724

1,341 605 644 294 104 2,988

44.9 20.3 21.5 9.9 3.5 100.0

7.7 10.8 6.6 6.5 8.8 7.9

24 2012

(Espicom, 2012) , 2011 801 26.8% . 453 15.2%, / 334 11.2% . 2006 / 16.0% , 8.6%, 8.4% . 2-2 (20062011)( : , %)2011 2006 2007 2008 2009 2010 (0611)

/ /

300 626 145 159 238 572 2,041

326 678 170 196 270 653 2,293

375 714 187 244 292 729 2,541

374 654 176 246 302 687 2,437

418 735 191 301 326 754 2,724

453 801 207 334 356 837 2,988

15.2 26.8 6.9 11.2 11.9 28.0 100.0

8.6 5.0 7.3 16.0 8.4 7.9 7.9

: , , , , , , : Espicom(2012)

2) Espicom(2012) 2017 4,344 , 2012 6.4% . , , , . / 2017 1,024 9.2% , / , 8.5% .

2 25

/ 2017 1,913 44.0% , 794 18.3%, 444 10.2% . 2-3 (20112017)( : , %)2017 2011 2012 2013 2014 2015 2016 (0611)

/ / / : Espicom(2012)

1,341 605 644 294 104 2,988

1,399 655 618 298 108 3,077

1,483 699 633 321 118 3,254

1,577 765 658 342 130 3,472

1,679 839 694 372 143 3,728

1,788 925 749 412 157 4,031

1,913 1,024 794 444 169 4,344

44.0 23.6 18.3 10.2 0.6 100.0

6.1 9.2 3.6 7.1 8.5 6.4

3) 2011 1,154 38.6% , 20 87.4% . 305(10.2%), 241(8.1%), 135(4.5%), 115(3.8%) . 2011 13(39) 1.3% .

26 2012

2-4 2011 ( : , %) 2010 2011

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

20

1,054 273 213 129 92 90 85 57 52 43 38 39 34 36 32 31 23 20 20 21 2,381 2,724

38.7 10.0 7.8 4.7 3.4 3.3 3.1 2.1 1.9 1.6 1.4 1.4 1.2 1.3 1.2 1.1 0.8 0.7 0.7 0.8 87.4 100.0

1,154 305 241 135 115 90 87 63 50 49 43 42 39 36 35 33 26 24 23 23 2,614 2,988

38.6 10.2 8.1 4.5 3.8 3.0 2.9 2.1 1.7 1.6 1.4 1.4 1.3 1.2 1.2 1.1 0.9 0.8 0.8 0.8 87.5 100.0

: 1. (-+) 2. 2011 : Espicom(2012) ; , ,

2 27

2006 2011 . 10 9.5% , 19.5% , 19.0%, 10.8% . 19 2006 15.4% . 2011 2005 8.2% 406 , 255, 149 . 2-5 (20062011)( : , %) 2006 2007 2008 2009 2010 2011 CAGR (0611)

1 2 3 4 5 6 7 8 9 10 19

273 174 94 45 67 42 72 55 55 40 8 917 1,214

302 207 105 58 73 54 80 60 59 46 10 1,043 1,380

348 236 123 81 89 70 94 78 62 52 11 1,232 1,597

352 222 113 86 89 71 91 81 57 52 12 1,214 1,554

384 238 134 110 94 85 95 86 65 59 15 1,349 1,725

406 (21.9) 255 (13.8) 149 (8.1) 109 (5.8) 105 (5.7) 102 (5.5) 94 (5.1) 92 (5.0) 68 (3.7) 62 (3.3) 17 (0.9) 1,442 (77.7) 1,856

8.2 8.0 9.7 19.0 9.5 19.5 5.3 10.8 4.4 9.3 15.4 9.5 8.9

10

: 1. 2. 2011 , ( ) : Espicom(2012)

28 2012

10 2006 2011 8.0% . 10 23.2%, 16.8% . 2011 353 1, 163, 116 , 2011 25 2006 7.0% . 2-6 (20062011)( : , %) 2006 2007 2008 2009 2010 2011 CAGR (0611)

1 2 3 4 5 6 7 8 9 10 17

249 108 76 80 87 42 30 70 52 35 18 830 1,234

276 123 77 88 87 56 36 76 56 40 22 915 1,396

306 140 88 102 105 75 44 83 63 44 21 1,049 1,609

288 138 89 103 101 83 52 73 63 43 19 1,032 1,557

324 146 108 110 103 83 68 70 63 46 23 1,120 1,697

353 (19.0) 163 (8.8) 116 (6.3) 112 (6.0) 111 (6.0) 91 (4.9) 86 (4.6) 72 (3.9) 62 (3.3) 51 (2.8) 25 (0.9) 1,216 (65.5) 1,860

7.2 8.6 8.9 6.9 4.9 16.8 23.2 0.5 3.3 7.6 7.0 8.0 8.6

10

: 1. 2. 2011 , ( ) : Espicom(2012)

2 29

2. 1) .

, , , , . 2-7

strong

/

3 , (0.9%) 65 4,100 13.2% 2009 2012

very strong very strong strong very strong

/

2.2% 2% ,

/

GDP 18.0% (2011) (, ) ( ) 2010 3 , 10 9,400 , 2011 : 1,154

/

+

fair

+

strong

+

(2017) : 1,578 (2012~2017) : 5.6% 30% , 2011 353, 2007 7.7%

very strong

+

: (Poor, Below average, Fair, Strong, Very Strong), (--, -, /, +, ++) : Espicom

30 2012

2011 2 6,965 GDP 18.0% , . 65 2011 13.2% . 2-8 (20072011)CAGR (0711)

2007

2008

2009

2010

2011

GDP 1 GDP 1 GDP 65 ( ) (Physicians) : Espicom

% %

14,028.7 46,517.3 2,252.3 7,468.3 16.1 301.6 12.6 5,708 3.1 776,554 2.6 634,005 2.1

14,291.6 46,953.8 2,360.1 7,753.8 16.5 304.4 12.7 5,815 3.1 784,199 2.6 647,954 2.1

13,938.9 45,400.0 2,454.2 7,994.2 17.6 307 12.9 5,795 3.1 792,805 2.6 650,794 2.1

14,526.6 46,820.0 2,598.4 8,376.6 17.9 310.2 13.0 5,754 3.0 801,058 2.6 655,530 2.1

15,006.0 47,910.0 2,696.5 8,609.5 18.0 313.2 13.2 5,749 3.0 809,396 2.6 659,372 2.1

1.7 0.7 4.6 3.6 0.9 0.2 -0.8 1.0 0.0 1.0 0.0

2011 1,154 2007 6.0% . 2011 367 31.8% , 355 30.8%, / 130 11.2% . / 2007 17.2% , 10.1% .

2 31

2-9 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

7,829 33,953 4,773 6,861 9,496 28,523 91,435

8,971 33,907 5,235 9,068 9,883 30,533 97,597

9,390 29,420 5,286 8,575 10,733 28,218 91,622

10,287 34,070 6,137 11,703 11,094 32,074 105,365

11,487 36,714 6,906 12,962 11,795 35,545 115,409

10.0 31.8 6.0 11.2 10.2 30.8 100.0

10.1 2.0 9.7 17.2 5.6 5.7 6.0

2017 1,578 , 2012 5.6% . , 485 5.0% , / 199 7.5% . 2-10 (20122017)( : , %) 2012 2013 2014 2015 2016 2017 CAGR (1217)

/ / : Espicom

12,033 38,061 7,211 13,799 12,275 37,018 120,397

12,676 39,712 7,578 14,767 12,843 38,790 126,366

13,412 41,646 8,003 15,870 13,497 40,849 133,277

14,209 43,732 8,462 17,074 14,201 43,071 140,749

15,055 45,926 8,949 18,372 14,941 45,414 148,657

16,024 48,475 9,512 19,852 15,788 48,120 157,771

5.9 5.0 5.7 7.5 5.2 5.4 5.6

32 2012

.

2011 401 2007 7.7% . , 2011 97(24.0%), 78 (19.2%), / 54(13.4%) . 2007 / 12.2% , 9.7%, 8.8% . , , 61(15.1%), (Electro-diagnostic apparatus) 55(13.5%). 2-11 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

5,393 7,687 1,247 3,441 3,706 8,713 30,188

6,396 8,460 1,399 4,745 3,742 10,060 34,802

6,547 8,547 1,322 4,730 3,962 10,118 35,226

7,178 9,404 1,421 5,370 3,814 11,193 38,381

7,798 9,718 1,415 5,449 3,984 12,201 40,563

19.2 24.0 3.5 13.4 9.8 30.1 100.0

9.7 6.0 3.2 12.2 1.8 8.8 7.7

2011 353 2007 6.4% . , 2011 83(23.4%), / 58(16.5%), 53(14.9%) , 2007 / 14.8% , 8.4%, / 7.3% .

2 33

2-12 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

3,821 7,755 1,281 3,362 3,943 7,437 27,598

4,359 7,892 1,398 4,727 4,186 8,032 30,595

4,404 6,840 1,338 4,345 4,428 7,424 28,779

4,704 7,703 1,547 5,426 4,591 8,464 32,433

5,275 8,272 1,697 5,843 4,908 9,333 35,329

14.9 23.4 4.8 16.5 13.9 26.4 100.0

8.4 1.6 7.3 14.8 5.6 5.8 6.4

, , , , 10 77.3% . 2-13 (2011)( : , %)

1 2 3 4 5 6 7 8 9 10

10

5,692 5,095 4,998 3,460 2,360 2,148 939 897 877 838 27,305 8,024 35,329

16.1 14.4 14.1 9.8 6.7 6.1 2.7 2.5 2.5 2.4 77.3 22.7 100.0

: Espicom

34 2012

, / , , , (50.2%) . 2 / (54.3%), (47.1%), (25.5%), / (35.4%) . 2-14 5 (2011)( : , %)

/ / / / : Espicom

5,692 1,398 452 72 272 643 2,855 24.6 7.9 1.3 4.8 11.3 50.2

5,095 637 126 149 2,765 839 579 12.5 2.5 2.9 54.3 16.5 11.4

4,998 187 2,357 410 534 221 1,290 3.7 47.1 8.2 10.7 4.4 25.8

3,460 523 836 116 252 884 848 15.1 24.2 3.4 7.3 25.5 24.5

2,360 362 207 241 835 315 400 15.3 8.8 10.2 35.4 13.3 17.0

2 35

2) .

, , . 2-15

Fair

+

1 ( 20%) 65 8.4% 2012 GDP 8.1 , 1 GDP 6,120 , 9(1979) 248(2011) GDP 5.2% (3,669, 2011) , 1 2.8(2008) 1 2 (1980~2008) 12,591(~2007) , / (compulsory insurance) 1,240 2011 : 115 (2017) : 349 (2012~2017) : 20.2% 2011 86( 26.6% ) 2007 24.5% , (high-end)

strong

+

Fair

++

Fair

++

Fair

++

strong

+

strong

+

very strong

+

: (Poor, Below average, Fair, Strong, Very Strong), (--, -, /, +, ++) : Espicom

36 2012

2011 GDP 7 35 2007 19.1% , 3,669 GDP 5.2% , 24.6% . 65 2011 8.4%( 1.1) . 2-16 (20072011) 2007 2008 2009 2010 2011 CAGR (0711)

GDP GDP 1 GDP 1 GDP 65 ( ) ( ) (Physicians) ( ) : Espicom

% % %

3,494.3 14.2 2,710 152.1 117.9 4.4 1,290 7.9 16,654 1.8 1,715,460 1.3 129,000 0.1

4,531.7 9.6 3,490 209.7 161.7 4.6 1,297 8.0 16,556 1.9 1,791,881 1.4 129,700 0.1

5,050.5 9.2 3,870 259.9 199.1 5.1 1,305 8.1 16,862 2.1 1,905,436 1.5 130,500 0.1

5,926.0 10.4 4,520 300.3 228.9 5.1 1,312 8.3 17,080 2.1 1,972,840 1.5 131,200 0.1

7,035.0 9.2 5,330 366.9 278.0 5.2 1,320 8.4 17,637 2.1 2,042,628 1.5 132,000 0.1

19.1 18.4 24.6 23.9 0.6 1.5 1.4 3.9 4.5 3.6 0.6 -

2011 115 2007 23.5% . 2011 48.7 42.3% , 21.6 18.8%, 18.6 16.2% . / 2007 33.1% , 26.9% .

2 37

2-17 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

716 2,202 108 243 777 890 4,936

943 2,541 146 325 962 1,149 6,066

1,161 2,963 181 373 1,121 1,367 7,166

1,445 3,841 228 482 1,439 1,788 9,223

1,858 4,867 339 551 1,718 2,161 11,494

16.2 42.3 2.9 4.8 14.9 18.8 100.0

26.9 21.9 33.1 22.7 21.9 24.8 23.5

2017 349 , 2012 20.2% . , 135.3 18.4% , 67.4 20.6% . 2-18 (20122017)( : , %) 2012 2013 2014 2015 2016 2017 CAGR (1217)

/ / : Espicom

2,289 5,822 435 657 2,114 2,640 13,957

2,820 6,963 560 781 2,601 3,223 16,948

3,414 8,198 710 915 3,147 3,871 20,255

4,129 9,649 903 1,070 3,805 4,643 24,199

4,990 11,357 1,150 1,251 4,596 5,564 28,908

6,093 13,533 1,485 1,480 5,615 6,743 34,949

21.6 18.4 27.8 17.6 21.6 20.6 20.2

38 2012

.

2011 102 2007 17.5% . , 2011 29.1(28.6%), 25.8 (25.4%), 21.1(20.7%) . 2007 / 44.9% , / 28.4%, 23.5% . , 18.9(18.6%), , 13.1(12.8%) . 2-19 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

1,512 1,109 126 43 1,383 1,167 5,340

2,074 1,511 177 84 1,597 1,534 6,977

2,024 1,658 220 96 1,528 1,525 7,051

2,297 2,099 252 139 1,785 1,871 8,442

2,908 2,579 342 192 2,108 2,044 10,172

28.6 25.4 3.4 1.9 20.7 20.1 100.0

17.8 23.5 28.4 44.9 11.1 15.0 17.5

2011 86 2007 24.5% . , 2011 41.2(48.2%), 15.7 (18.4%) 11.1(13.0%) . 2007 / 35.9%, 27.9%, 27.1% .

2 39

2-20 (20072011)( : , %) 2007 2008 2009 2010 2011 CAGR (0711)

/ / : Espicom

380 1,862 70 220 432 601 3,564

516 2,122 97 292 552 772 4,352

633 2,494 127 335 679 978 5,244

780 3,238 158 433 894 1,253 6,757

1,017 4,121 240 496 1,108 1,569 8,552

11.9 48.2 2.8 5.8 13.0 18.4 100.0

27.9 22.0 35.9 22.6 26.5 27.1 24.5

, , , 10 84.7% . 2-21 (2011)( : , %)

1 2 3 4 5 6 7 8 9 10

10

2,849 1,587 1,192 348 301 268 213 181 154 153 7,245 1,307 8,552

33.3 18.6 13.9 4.1 3.5 3.1 2.5 2.1 1.8 1.8 84.7 15.3 100.0

: Espicom

40 2012

, , X-ray (48.8%) . 2 (56.3%), (58.4%), (42.1%), (89.2%) . 2-22 5 (2011)( : , %)

/ / / / : Espicom

2,849 397 1,389 23 238 283 518 13.9 48.8 0.8 8.4 10.0 18.2

1,587 63 893 40 61 138 392 4.0 56.3 2.5 3.8 8.7 24.7

1,192 154 696 25 11 22 285 12.9 58.4 2.1 0.9 1.8 23.9

348 36 13 39 58 147 56 10.3 3.7 11.1 16.6 42.1 16.2

301 14 268 0 1 16 2 4.5 89.2 0.0 0.2 5.4 0.6

2 41

3) .

, , , . 2011 GDP 3.6 , . 2-23

strong

-

1 (8,150, 2012) 65 20.4% GDP 3.6(2011)

strong

/

, GDP 11.7% (2011)

strong

/

77% , 50% (, ) ( ). (uptake) . , , , . ,

strong very strong

+

+

strong

+

, 2007 7 2011 : 241

strong

+

(2017) : 320 (2012~2017) : 6.6% 2011 167, 2007 7.0%

fair

+

: (Poor, Below average, Fair, Strong, Very Strong), (--, -, /, +, ++) : Espicom

42 2012

2011 4,183 GDP 11.7% , . 65 2011 20.4%, . 2-24 (20072011)CAGR (0711)

2007

2008

2009

2010

2011

GDP

% % %

3,329.2 3.4 40,493 348.6 4,240.0 10.5 82 19.8 2,087 6.2 314,912 3.8 65,842 0.8

3,637.6 0.8 44,360 388.9 4,743.1 10.7 82 20.1 2,083 6.1 319,697 3.9 66,349 0.8

3,308.3 -5.1 40,443 387.8 4,740.8 11.7 82 20.3 2,084 6.2 325,945 4 67,167 0.8

3,288.2 3.6 40,240 382.6 4,682.2 11.6 82 20.4 2,064 6.2 333,599 4.1 67,808 0.8

3,588.0 3.1 43,930 418.3 5,122.2 11.7 82 20.4 2,047 6.2 337,764 4.1 68,269 0.8

1.9 2.1 4.7 4.8 -0.2 -0.5 1.8 1.9 0.9 -

GDP 1 GDP 1 GDP

65 ( ) ( ) (Physicians)

( ) : Espicom

2011 241 2007 6.6% . 2011 55.4 23.0%, 57 23.7%, 48.3 20.0% . / 2007 13.5% .

2 43

2-25 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

3,535 5,042 1,829 1,590 2,173 4,448 18,617

4,164 5,124 2,082 1,989 2,171 5,075 20,605

4,164 5,193 2,026 2,087 2,132 4,892 20,494

4,153 5,149 2,161 2,213 2,560 5,077 21,313

4,827 5,537 2,279 2,642 3,102 5,696 24,083

20.0 23.0 9.5 11.0 12.9 23.7 100.0

8.1 2.4 5.7 13.5 9.3 6.4 6.6

2017 320 2012 6.6% . , 73.1 5.9% , / 199( 11.1%) . 2-26 (20122017)( : , %) 2012 2013 2014 2015 2016 2017 CAGR (1217)

/ / : Espicom

4,729 5,177 2,158 2,665 3,051 5,477 23,257

4,950 5,184 2,192 2,874 3,204 5,633 24,037

5,290 5,290 2,267 3,161 3,433 5,908 25,349

5,778 5,524 2,401 3,556 3,759 6,336 27,354

6,382 5,826 2,568 4,043 4,158 6,868 29,845

6,921 6,032 2,698 4,511 4,514 7,306 31,982

7.9 3.1 4.6 11.1 8.1 5.9 6.6

44 2012

.

2011 261 2007 5.7% . , 2011 83(31.7%), 37 (14.0%) . 2007 / 15.5% , 9.2%, 8.9% . , X-ray 32(12.3%), (Electrodiagnostic apparatus) 27(10.5%) . 2-27 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

2,593 7,657 1,818 1,282 1,644 5,949 20,943

3,151 8,372 1,986 1,455 1,934 6,760 23,657

2,995 7,569 1,961 1,536 1,950 6,140 22,152

3,175 7,526 2,054 1,807 2,094 6,395 23,051

3,653 8,287 2,309 2,280 2,340 7,252 26,120

14.0 31.7 8.8 8.7 9.0 27.8 100.0

8.9 2.0 6.2 15.5 9.2 5.1 5.7

2011 167 2007 7.0% . , 40(24.1%), 32(18.9%), 26(15.5%) . 2007 / 13.2% .

2 45

2-28 (20072011)( : , %) 2007 2008 2009 2010 2011 CAGR (0711)

/ / : Espicom

2,909 2,872 849 1,117 1,827 3,156 12,730

3,285 2,928 967 1,409 1,821 3,589 14,000

3,344 2,835 930 1,470 1,784 3,451 13,815

3,457 2,873 996 1,542 2,136 3,588 14,592

4,014 3,156 1,066 1,832 2,585 4,027 16,680

24.1 18.9 6.4 11.0 15.5 24.1 100.0

8.4 2.4 5.8 13.2 9.1 6.3 7.0

, , , , , 10 75.7% . 2-29 (2011)( : , %)

1 2 3 4 5 6 7 8 9 10

10

2,951 2,156 1,599 1,396 1,213 868 793 754 523 373 12,626 4,055 16,680

17.7 12.9 9.6 8.4 7.3 5.2 4.8 4.5 3.1 2.2 75.7 24.3 100.0

: Espicom

46 2012

, (27.1%) . 2 (24.1%), (23.9%), (46.6%), (29.0%) . 2-30 5 (2011)( : , %)

/ / / / : Espicom

2,951 310 800 176 392 606 667 10.5 27.1 6.0 13.3 20.6 22.6

2,156 485 420 94 311 519 328 22.5 19.5 4.3 14.4 24.1 15.2

1,599 333 76 340 240 228 382 20.8 4.8 21.3 15.0 14.3 23.9

1,396 650 60 18 234 77 356 46.6 4.3 1.3 16.8 5.5 25.5

1,213 230 351 45 253 58 275 19.0 29.0 3.7 20.9 4.8 22.6

2 47

4) .

, , , . 2-31

very strong

2012 1 9,470 ( 1.0% ) + , 65 6.9% (2012 1,360 ) 2012 GDP 2.4 , 3.0% GDP 8.8% (2011)

strong

+

fair

+

2008 2011 , 47.3% ( ) ,

fair

+

strong

+

(ABIMO) 2011 59, 7 2008 3 1,000 7 2,000

fair

+

2007 12 Mais Saude programme (Unified Health System) 2011 : 43.2

strong

+

(2017) : 83.6 (2012~2017) : 13.6% 2011 26 ( 8.1%), 2007 16.6%

strong

+

: (Poor, Below average, Fair, Strong, Very Strong), (--, -, /, +, ++) : Espicom

48 2012

2011 2,198 GDP 8.8% , . 65 2011 6.7% . 2-32 (20072011) 2007 2008 2009 2010 2011 CAGR (0711)

GDP

% % %

1,366.3 6.1 7,410 115.7 627.3 8.5 185 6.1 6,704 2.4 246,338 1.3 80,159 0.4

1,652.8 5.2 8,860 136.9 734.0 8.3 187 6.3 6,713 2.4 266,136 1.4 88,590 0.5

1,621.7 -0.3 8,600 139.6 740.1 8.8 189 6.4 6,792 2.3 278,246 1.5 96,525 0.5

2,141.9 7.5 11,229 192.9 1,011.5 9 191 6.6 6,798 2.4 288,294 1.5 93,228 0.5

2,485.0 2.7 12,890 219.8 1,140.3 8.8 193 6.7 6,698 2.4 284,612 1.5 89,930 0.5

16.1 14.8 17.4 16.1 1.1 -0.0 3.7 3.6 2.9 5.7

GDP 1 GDP 1 GDP

65 ( ) ( )

(Physicians) ( )

: Espicom

2011 43.2 2007 18.5% . 2011 11.4 26.4% . , 9.2(21.3%) , 8.7 20.0% . 2007 26.0%, 26.4%, / 24.7% .

2 49

2-33 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

557 599 128 290 273 343 2,190

634 718 162 396 317 496 2,723

707 685 160 421 345 526 2,844

893 922 219 528 510 723 3,795

1,142 923 310 608 476 865 4,324

26.4 21.3 7.2 14.1 11.0 20.0 100.0

19.7 11.4 24.7 20.3 14.9 26.0 18.5

2017 83.4 2012 13.6% . , 2017 21.6 13.1% , 19.4 16.4%, / 12.5 14.7% . 2-34 (20122017)( : , %) 2012 2013 2014 2015 2016 2017 CAGR (1217)

/ / : Espicom

1,165 918 314 628 483 908 4,416

1,331 1,023 357 728 549 1,066 5,054

1,501 1,127 401 831 614 1,234 5,708

1,685 1,244 449 947 688 1,428 6,441

1,896 1,383 503 1,081 774 1,657 7,294

2,155 1,560 570 1,247 881 1,944 8,357

13.1 11.2 12.7 14.7 12.8 16.4 13.6

50 2012

.

2011 5.6 2007 5.3% . , 2011 2.5(45.3%), / 1.2(21.1%), / 0.9(15.3%) . 2007 / 12.8% , 7.3% . 2-35 (20072011)( : , %)2011 2007 2008 2009 2010 CAGR (0711)

/ / : Espicom

198 25 81 72 23 51 451

209 32 81 85 18 56 482

211 25 69 89 13 41 447

235 29 83 98 13 44 502

251 33 85 117 15 54 555

45.3 5.9 15.3 21.1 2.7 9.7 100.0

6.2 7.3 1.1 12.8 -10.1 1.1 5.3

2011 26.2 2007 16.6% . , 2011 8.4(31.9%), 5.3 (20.2%) 4.4(16.9%) . 2007 / 23.8%, 22.8% .

2 51

2-36 (20072011)( : , %) 2007 2008 2009 2010 2011 CAGR (0711)

/ / : Espicom

215 543 35 139 253 233 1,418

248 653 43 192 291 327 1,755

279 622 43 203 319 334 1,800

353 835 58 255 454 466 2,422

442 836 82 295 435 528 2,618

16.9 31.9 3.1 11.2 16.6 20.2 100.0

19.7 11.4 23.8 20.6 14.5 22.8 16.6

, , , , , 10 83.6% . 2-37 (2011)( : , %)

1 2 3 4 5 6 7 8 9 10

10

935 367 213 153 139 107 86 66 52 50 2,169 426 2,595

36.0 14.1 8.2 5.9 5.4 4.1 3.3 2.5 2.0 1.9 83.6 16.4 100.0

: Espicom

52 2012

, (30.3%) . , , 32.5%, 43.5%, 75.6% . (42.3%) . 2-38 5 (2011)( : , %)

/ / / / : Espicom

935 168 283 7 146 102 229 18.0 30.3 0.8 15.6 10.9 24.4

367 37 119 17 27 69 97 10.0 32.5 4.7 7.5 18.8 26.5

213 47 93 4 8 14 46 22.2 43.5 1.8 3.9 6.8 21.8

153 10 116 5 0 1 21 6.8 75.6 3.0 0.0 0.7 13.8

139 13 2 23 32 59 11 9.2 1.7 16.2 23.1 42.3 7.6

3 53

3

1. 1) ( ) 2011 4 3,064 2010 3 9,027 10.3% .

3-1 ( )

54 2012

2006 2011 8.3% . 2011 3 3,665 2010 2 9,644 13.6% . 2006 2011 11.5% . 2006 2011 18.9% , 2011 1 8,538 2010 10.2% . 2011 2010 6.6% 2 7,937, 2006 2011 10.2% . 2011 9,399 0.2% . 2011 64.9% 2.3%p . , 2011 . 2006 6067% . 3-1 ( : , %) 2006 2007 2008 2009 2010 2011 (0611)

1,949,159 (14.4) 781,043 (9.1) 1,719,323 (11.2) -938,280 (13.0) 2,887,438 (13.9) 59.5

2,216,965 (13.7) 959,094 (22.8) 2,001,423 (16.4) -1,042,329 (11.1) 3,259,294 (12.9) 61.4

2,525,203 (13.9) 1,248,138 (30.1) 2,340,883 (17.0) -1,092,745 (4.8) 3,617,947 (11.0) 64.7

2,764,261 (9.5) 1,519,027 (21.7) 2,398,814 (2.5) -879,787 (19.5) 3,644,047 (0.7) 65.8

2,964,445 (7.2) 1,681,619 (10.7) 2,619,895 (9.2) -938,276 (6.6) 3,902,720 (7.1) 67.1

3,366,462 (13.6) 1,853,785 (10.2) 2,793,709 (6.6) -939,925 (0.2) 4,306,387 (10.3) 64.9

11.5 18.9 10.2 8.3 -

: 1. ( ) 2. -+, / 3. : , ,

3 55

2) 2011 1,958 2010 1,857 5.4% , ( ) 1,570 2010 1,496 4.9% . 2005 3.5%, 5.2% . 3-2 ( : , %) 2005 2006 2007 2008 2009 2010 2011 (0511)

1,596 (6.4) 1,157 (16.0)

1,624 (1.8) 1,281 (10.7)

1,662 (2.3) 1,381 (7.8)

1,726 (3.9) 1,456 (5.4)

1,754 (1.6) 1,466 (0.7)

1,857 (5.9) 1,496 (2.0)

1,958 (5.4) 1,570 (4.9)

3.5 5.2

: 1. 2. ( ) : , ,

3) 2011 32,255, 17,712 . 6.8% , 2008 2010 9.8%, 2011 2.9% . 2005 2011 3.9%, 6.0% . 3-3 ( : , %) 2005 2006 2007 2008 2009 2010 2011 (0511)

25,610 (1.3) 12,469 (1.9)

26,399 ( 3.1) 14,634 (17.4)

26,936 ( 2.0) 17,429 (19.1)

27,527 (2.2) 16,866 (3.2)

28,167 (2.3) 15,677 (7.0)

30,190 (7.2) 17,219 (9.8)

32,255 (6.8) 17,712 (2.9)

3.9 6.0

: , ( ) : , ,

56 2012

, 2010 9,892, 4,632 45.1% . , . 2011 12,267 69.3% , 13.4% . 3-4 ( : , %) 2009 2010 2011 2009 2010 2011

28,167(100.0) 4,371 (15.5) 929 (3.3) 1,565 (5.6) 8,900 (31.6) 2,520 (8.9) 1,893 (6.7) 1,144 (4.1) 998 (3.5) 813 (2.9) 1,972 (7.0) 23 (0.1) 817 (2.9) 1,454 (5.2) 69 (0.2) 205 (0.7) 491 (1.7) 3 (0.0)

30,190(100.0) 4,345 (14.4) 927 (3.1) 2,358 (7.8) 9,368 (31.0) 2,810 (9.3) 1,848 (6.1) 1,478 (4.9) 1,469 (4.9) 894 (3.0) 1,463 (4.8) 26 (0.1) 834 (2.8) 1,457 (4.8) 80 (0.3) 263 (0.9) 563 (1.9) 7 (0.0)

32,255(100.0) 4,632 (14.4) 906 (2.8) 2,271 (7.0) 9,892 (30.7) 2,919 (9.0) 1,990 (6.2) 2,057 (6.4) 1,346 (4.2) 1,064 (3.3) 1,533 (4.8) 58 (0.2) 904 (2.8) 1,512 (4.7) 91 (0.3) 386 (1.2) 667 (2.1) 27 (0.1)

15,677(100.0) 10,920 (69.7) 191 (1.2) 530 (3.4) 2,267 (14.5) 253 (1.6) 268 (1.7) 361 (2.3) 178 (1.1) 194 (1.2) 147 (0.9) 3 (0.0) 135 (0.9) 87 (0.6) 91 (0.6) 52 (0.3) 0 (0.0)

17,219(100.0) 11,878 (69.0) 94 (0.5) 742 (4.3) 2,256 (13.1) 665 (3.9) 159 (0.9) 374 (2.2) 205 (1.2) 253 (1.5) 173 (1.0) 4 (0.0) 134 (0.8) 169 (1.0) 13 (0.1) 69 (0.4) 31 (0.2) - (0.0)

17,712(100.0) 12,267 (69.3) 133 (0.8) 918 (5.2) 2,374 (13.4) 247 (1.4) 161 (0.9) 446 (2.5) 285 (1.6) 200 (1.1) 184 (1.0) 2 (0.0) 161 (0.9) 159 (0.9) 13 (0.1) 83 (0.5) 79 (0.4) - (0.0)

: ( ) : , ,

, 1 2004 ( 3-5 ).

3 57

2011 1 1 440 6.3% . 6.8%, 13.6% . 1 2005 2009 713% , 2010 0.1% , 2011 6.3% . 3-5 1 (, %) (, %) (, %) 1 (, %)

2003 2004 2005 2006 2007 2008 2009 2010 2011

1,012 (7.9) 1,500 (48.2) 1,596 (6.4) 1,624 (1.8) 1,662 (2.3) 1,726 (3.9) 1,754 (1.6) 1,857 (5.9) 1,958 (5.4)

21,766 (5.2) 25,287 (16.2) 25,610 (1.3) 26,399 (3.1) 26,936 (2.0) 27,527 (2.2) 28,167 (2.3) 30,190 (7.2) 32,255 (6.8)

1,327,106 (1.6) 1,478,165 (11.4) 1,704,161 (15.3) 1,949,159 (14.4) 2,216,965 (13.7) 2,525,203 (13.9) 2,764,261 (9.5) 2,964,445 (7.2) 3,366,462 (13.6)

61.0 (6.4) 58.5 (4.1) 66.5 (13.8) 73.8 (11.0) 82.3 (11.5) 91.7 (11.5) 98.1 (7.0) 98.2 (0.1) 104.4 (6.3)

: 1. ( ) 2. , , : , ,

( 3-6 ), 2011 100 51(2.6%) , 100 1,907(97.4%) 2010 103 , 20 73 . 100 2011 1 2,967 38.4% , 100 2 698 61.5% . 2010 100 3.6%p .

58 2012

1 300 , 2011 1.95 . 100 (51) 1 1.37 100 (1,717) . 100 2009 0.85, 2010 0.82 , 2011 0.91 . 20 2011 1,591 , 2011 0.67 . 3-6 ( : , , , %) 1

2009 2010 2011 2009 2010 2011 2009 2010 2011 2009 2010 2011

300 200 300 100 200 (100 ) 50 100

4 (0.2) 9 (0.5) 29 (1.7) 42 (2.4) 63 (3.6)

3 (0.2) 13 (0.7) 37 (2.0) 53 (2.9) 68 (3.7) 218 (11.7) 1,518 (81.7) 1,804 (97.1)

4 (0.2) 13 (0.7) 34 (1.7) 51 (2.6) 85 (4.3) 231 (11.8) 1,591 (81.3) 1,907 (97.4)

1,811 (6.4) 2,241 (8.0) 4,067 (14.4) 8,119 (28.8) 4,578 (16.3) 6,337 (22.5) 9,133 (32.4) 20,048 (71.2)

1,039 (3.4) 3,207 (10.6) 4,978 (16.5) 9,224 (30.6) 4,728 (15.7) 6,604 (21.9) 9,634 (31.9) 20,966 (69.4)

1,687 4,081.9 (5.2) (14.8) 3,095 1,728.2 (9.6) (6.3) 4,684 4,823.1 (14.5) (17.4) 9,466 10,633.2 (29.3) (38.5) 6,001 5,005.3 (18.6) (18.1) 6,870 5,487.2 (21.3) (19.9) 9,918 6,516.9 (30.7) (23.6) 22,789 17,009.4 (70.7) (61.5)

3,279 (11.1) 3,169 (10.7) 6,043 (20.4) 12,491 (42.1) 4,709 (15.9) 5,996 (20.2) 6,448 (21.8) 17,153 (57.9) 29,644 (100.0)

3,294 (9.8) 3,583 (10.6) 6,090 (18.1) 12,967 (38.5) 7,199 (21.4) 6,810 (20.2) 6,689 (19.9) 20,698 (61.5) 33,665 (100.0)

2.25

3.16

1.95

0.77

0.99

1.16

1.19

1.21

1.30

1.31

1.35

1.37

1.09

1.00

1.20

20 203 50 (11.6) 20 1,446 (82.4)

0.87

0.91

0.99

0.71

0.67

0.67

1,712 (100 ) (97.6)

0.85

0.82

0.91

1,754 1,857 1,958 28,167 30,190 32,255 27,642.6 (100.0) (100.0) (100.0) (100.0) (100.0) (100.0) (100.0)

0.98

0.98

1.04

: ( ) : , ,

3 59

4) ( 3-7 ), 10 2011 1,528 77.8% 2,560 7.6% . , 10 435 3 1,105 92.4% . 100 (2008 42 2011 62) . 100 2008 51.2% 2011 55.6% . 1050 , 10 . 3-7 ( : , , %) 2008 2009 2010 2011

100 50100 1050 (10 ) 110 1 (10 )

42 (2.4) 61 (3.5) 253 (14.7) 356 (20.6) 528 (30.6) 842 (48.8) 1,370 (79.4) 1,726

12,932 (51.2) 4,268 (16.9) 5,824 (23.1) 23,024 (91.2) 2,076 (8.2) 152 (0.6) 2,228 (8.8) 25,252

48 (2.7) 74 (4.2) 239 (13.6) 361 (20.6) 566 (32.3) 827 (47.1) 1,393 (79.4) 1,754

14,666 (53.1) 5,121 (18.5) 5,433 (19.7) 25,220 (91.2) 2,262 (8.2) 161 (0.6) 2,422 (8.8) 27,643

56 (3.0) 58 (3.1) 285 (15.3) 399 (21.5) 601 (32.4) 857 (46.1) 1,458 (78.5) 1,857

16,170 (54.5) 4,193 (14.1) 6,746 (22.8) 27,109 (91.4) 2,367 (8.0) 169 (0.6) 2,536 (8.6) 29,644

62 (3.2) 81 (4.1) 292 (14.9) 435 (22.2) 631 (32.2) 892 (45.6) 1,523 (77.8) 1,958

18,704 (55.6) 5,803 (17.2) 6,598 (19.6) 31,105 (92.4) 2,389 (7.1) 170 (0.5) 2,560 (7.6) 33,665

: ( ) : , ,

60 2012

( 3-8 ), 1 2011 20.1% 6,782 , 2010 14.9% . 2 2011 1 3,541 40.2% , 2010 7.5% . 2008 . 2011 3 2010 15.4% 1 1,848 35.2% 2010 . 4 2010 69.6% 1,493 4.4% 1.4%p . 3, 4 . 34 (2009 4 ) . 3-8 (14) ( : , %) 2008 2009 2010 2011 2010

1 2 3 4

478,914 1,139,446 769,857 136,986 2,525,203

19.0 45.1 30.5 5.4 100.0

532,359 1,252,471 893,625 85,806 2,764,261

19.3 45.3 32.3 3.1 100.0

590,331 1,259,565 1,026,505 88,044 2,964,445

19.9 42.5 34.6 3.0 100.0

678,201 1,354,121 1,184,834 149,306 3,366,462

20.1 40.2 35.2 4.4 100.0

14.9 7.5 15.4 69.6 13.6

: , ,

( 3-9 ), 2011 7,195(21.4%) , (6,174), (5,644) .

3 61

2010 93.2% , (56.6%), (43.5%) . 3-9 ( : , %)2008 2009 2010 2011 2010

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

()

548,229 107,830 76,153 87,280 27,850 167,843 77,373 73,419 9,183 11,306 435,449 53,600 516,602 253,697 79,389 -

21.7 4.3 3.0 3.5 1.1 6.6 3.1 2.9 0.4 0.4 17.2 2.1 20.5 10.0 3.1 -

623,362 122,484 99,890 98,307 26,241 183,184 88,484 78,846 18,937 18,264 496,647 50,484 506,668 261,783 90,680 -

22.6 4.4 3.6 3.6 0.9 6.6 3.2 2.9 0.7 0.7 18.0 1.8 18.3 9.5 3.3 -

716,850 138,763 113,874 96,992 29,780 224,883 95,395 110,946 9,260 15,480 506,033 55,758 512,900 230,458 107,073 -

24.2 4.7 3.8 3.3 1.0 7.6 3.2 3.7 0.3 0.5 17.1 1.9 17.3 7.8 3.6 -

719,458 164,584 157,842 92,703 27,451 274,784 122,920 159,214 17,890 24,241 564,428 56,214 617,377 253,035 112,430 1,893

21.4 4.9 4.7 2.8 0.8 8.2 3.7 4.7 0.5 0.7 16.8 1.7 18.3 7.5 3.3 0.1

0.4 18.6 38.6 -4.4 -7.8 22.2 28.9 43.5 93.2 56.6 11.5 0.8 20.4 9.8 5.0 n.a 13.6

2,525,203 100.0 2,764,261 100.0 2,964,445 100.0 3,366,462 100.0

: , ,

, 30 ( 3-10 ), 2011 30 2 3,408 69.5% . 2011 1 (3,804), (2,497) 2, (2,319) 3 .

62 2012

3-10 2011 30 ( : , %) 2009 2010 2011 2010

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

A26380 C12050 C01020 A77010 A77030 A83060 A83080 B03160 A58020 A37010 A11110 A54010 B10010 A26430 A68010 A11010 A78010 A79030 B05010 A55030 C12090 A79010 A22030 A86010 A02010 A11020 A53010 A37020 A17100 A79160

30 (A)

286,733 (1) 179,144 (3) 253,955 (2) 167,563 (4) 72,260 (7) 131,439 (5) 68,797 (10) 39,129 (15) 70,368 (8) 58,176 (12) 68,919 (9) 64,522 (11) 35,538 (16) 77,688 (6) 46,649 (14) 53,713 (13) 28,366 (20) 33,895 (17) 31,685 (19) 27,871 (21) 17,317 (29) 25,306 (23) 16,544 (31) 27,065 (22) 33,471 (18) 17,409 (28) 19,965 (25) 15,695 (33) 12,950 (41) 15,765 (32) 1,997,896 2,764,261 72.3

330,779 (1) 188,001 (3) 229,562 (2) 160,849 (4) 78,726 (9) 81,122 (8) 82,324 (7) 57,586 (13) 94,593 (6) 63,626 (12) 102,657 (5) 65,182 (11) 35,627 (19) 69,932 (10) 47,403 (14) 43,233 (15) 40,094 (16) 34,659 (20) 35,819 (18) 33,705 (21) 23,077 (24) 27,325 (22) 22,101 (26) 27,323 (23) 37,428 (17) 19,671 (31) 21,939 (27) 18,722 (32) 14,876 (40) 17,408 (34) 2,105,347 2,964,445 71.0

380,432 249,717 231,924 177,089 99,034 94,892 93,206 89,694 82,340 72,491 69,753 60,716 59,664 47,050 44,408 44,361 43,006 39,526 38,465 37,476 36,588 33,587 32,760 28,972 27,143 25,873 25,687 25,528 25,428 23,960 2,340,766 3,366,462 69.5

15.0 32.8 1.0 10.1 25.8 17.0 13.2 55.8 13.0 13.9 32.1 6.9 67.5 32.7 6.3 2.6 7.3 14.0 7.4 11.2 58.5 22.9 48.2 6.0 27.5 31.5 17.1 36.4 70.9 37.6 11.2 13.6 -

(B) (A/B)

: ( ) : , ,

3 63

2011 20 35.9% 1 2,072. () 2,347(7.0%) (), (), () , () . () 250.2% 360, () 206.1% 295 . 3-11 2011 20( : , %) 2010 2011 2010 2011

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

() () () () () () () () () () () () () () () () () () () () 20

232,492 56,390 40,259 55,234 71,417 28,437 60,929 48,970 56,903 95,182 53,976 47,004 27,903 43,814 10,277 32,133 23,609 22,050 9,653 28,219 1,044,848 2,964,445

234,748 91,183 80,640 68,406 61,325 61,038 60,712 58,976 54,769 54,123 52,992 52,219 46,263 43,818 35,986 33,331 30,772 29,898 29,544 26,480 1,207,224 3,366,462

7.8 1.9 1.4 1.9 2.4 1.0 2.1 1.7 1.9 3.2 1.8 1.6 0.9 1.5 0.3 1.1 0.8 0.7 0.3 1.0 35.2 100.0

7.0 2.7 2.4 2.0 1.8 1.8 1.8 1.8 1.6 1.6 1.6 1.6 1.4 1.3 1.1 1.0 0.9 0.9 0.9 0.8 35.9 100.0

1.0 61.7 100.3 23.8 14.1 114.6 0.4 20.4 3.7 43.1 1.8 11.1 65.8 0.0 250.2 3.7 30.3 35.6 206.1 6.2 15.5 13.6

: , ,

64 2012

5) 2011 , 2011 (1,423) 4 3,317( 2 1,917, 2 1,399), (1,195) 5 7,124 .

15 1 1,424 26.4% , (7,945, 18.3%) . 3-12 (2011)( : , %)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

()

794,517 298,080 333,682 127,321 52,997 326,735 71,027 201,863 23,124 26,000 1,142,448 191,062 429,038 159,202 154,603 4,331,698

18.3 6.9 7.7 2.9 1.2 7.5 1.6 4.7 0.5 0.6 26.4 4.4 9.9 3.7 3.6 100.0

172,136 101,467 99,733 58,340 47,472 208,913 35,283 136,982 16,315 16,120 617,442 80,185 342,520 138,861 119,978 2,191,747

7.9 4.6 4.6 2.7 2.2 9.5 1.6 6.2 0.7 0.7 28.2 3.7 15.6 6.3 5.5 100.0

622,381 196,613 233,949 68,981 5,525 117,822 35,744 64,881 6,809 9,880 525,005 110,876 86,518 20,341 34,625 2,139,951

29.1 9.2 10.9 3.2 0.3 5.5 1.7 3.0 0.3 0.5 24.5 5.2 4.0 1.0 1.6 100.0

: (2012). 2011

3 65

2011 1 1,145(19.5%), (13.5%, 7,711), (12.5%, 7,163), (12.5%, 7,140) . 3-13 (2011)( : , %)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

()

771,111 186,223 714,043 115,795 167,243 350,520 340,040 716,301 339,239 214,838 1,114,501 199,481 281,155 42,179 159,687 5,712,354

13.5 3.3 12.5 2.0 2.9 6.1 6.0 12.5 5.9 3.8 19.5 3.5 4.9 0.7 2.8 100.0

769,003 171,561 639,223 78,140 164,947 309,276 336,900 506,277 321,599 214,106 1,032,456 154,638 274,612 23,953 147,491 5,144,183

14.9 3.3 12.4 1.5 3.2 6.0 6.5 9.8 6.3 4.2 20.1 3.0 5.3 0.5 2.9 100.0

2,107 14,663 74,819 37,656 2,296 41,243 3,140 210,024 1,368 732 98,315 44,843 6,543 18,226 12,196 568,172

0.4 2.6 13.2 6.6 0.4 7.3 0.6 37.0 0.2 0.1 17.3 7.9 1.2 3.2 2.1 100.0

: (2012). 2011

66 2012

6) 2011 15.0%, 11.3% , . 2005 , 2007 2010 . 2011 2010 14.5 16.7 , 22.7 25.2 , 8.48 . 2005 2011 15.7% , 8.9% . 2007 2008, 2009 , 2011 ( 3-2 ).

3-2 : , ,

( 3-14 ), 2011 1 2010 13.4% 3.7 22.1% , 2 5.07 30.3% .

3 67

3 7.58 45.3% , 4 2010 0.16 144.2% 0.38 . 1, 2 , 4 1.2%p . 3 4 2010 45.7% 2011 47.6% . 3-14 (14) ( : , %)2008 2009 2010 2011 2010

1 2 3 4

241,832 351,338 509,682 29,153 1,132,005

21.4 31.0 45.0 2.6 100.0

271,206 393,347 482,900 42,633 1,190,087

22.8 33.1 40.6 3.6 100.0

326,102 463,892 648,708 15,659 1,454,361

22.4 31.9 44.6 1.1 100.0

369,831 506,659 758,202 38,232 1,672,925

22.1 30.3 45.3 2.3 100.0

13.4 9.2 16.9 144.2 15.0

: , ,

2011 1,000 2010 29 33 ( 3-15 ). 10.3 61.4% . 100 500 142 15 , 3.4 0.39 . 2010 583 2011 619 36 , 1,000 8 , 20 254 7.6% . 100 204 15.7 93.8% .

68 2012

3-15 ( : , , %)2008 2009 2010 2011

1,000 500 1,000 100 500 50 100 20 50 20

19 (4.0) 27 (5.7) 98 (20.7) 50 (10.6) 79 (16.7) 200 (42.3)

647,406 (57.2) 181,820 (16.1) 228,698 (20.2) 35,626 (3.2) 26,452 (2.3) 12,003 (1.1)

21 (4.1) 29 (5.6) 108 (20.8) 61 (11.8) 67 (12.9) 232 (44.8)

674,329 (56.7) 201,091 (16.9) 236,287 (19.9) 42,218 (3.5) 21,257 (1.8) 14,906 (1.3)

29 (5.0) 27 (4.6) 127 (21.8) 78 (13.4) 86 (14.8) 236 (40.5)

861,574 (59.2) 195,518 (13.4) 298,781 (20.5) 56,330 (3.9) 27,515 (1.9) 14,644 (1.0)

33 (5.3) 29 (4.7) 142 (22.9) 82 (13.2) 79 (12.8) 254 (41.0) 619 (100.0)

1,027,626 (61.4) 203,617 (12.2) 338,557 (20.2) 59,274 (3.5) 27,360 (1.6) 16,491 (1.0) 1,672,925 (100.0)

473 1,132,005 (100.0) (100.0)

518 1,190,087 (100.0) (100.0)

583 1,454,361 (100.0) (100.0)

: ( ) : , ,

1,000 2011 48 2010 44 4 2010 14.8 2011 16.5 12.2% ( 3-16 ). 20 971 61.9% , 0.39 1.6% . 100 500 2011 178 11.3% , 3.99 15.9% .

3 69

3-16 ( : , , %)2008 2009 2010 2011

1,000 500 1,000 100 500 50 100 20 50 20

45 1,357,886 (3.1) (64.0) 32 (2.2) 160 (11.0) 129 (8.9) 173 (11.9) 917 (63.0) 220,824 (10.4) 361,963 (17.0) 90,766 (4.3) 56,721 (2.7) 34,917 (1.6)

35 1,107,293 (2.4) (58.9) 32 (2.2) 160 (10.9) 121 (8.3) 160 (10.9) 958 (65.3) 238,908 (12.7) 355,856 (18.9) 86,288 (4.6) 52,864 (2.8) 38,150 (2.0)

44 (2.9) 30 (2.0) 173 (11.6) 114 (7.6) 203 (13.6) 932 (62.3) 1,496 (100.0)

1,475,031 (65.1) 206,132 (9.1) 399,257 (17.6) 81,321 (3.6) 66,490 (2.9) 37,605 (1.7) 2,265,836 (100.0)

48 (3.1) 42 (2.7) 178 (11.3) 127 (8.1) 204 (13.0) 971 (61.8) 1,570 (100.0)

1,654,895 (65.6) 272,314 (10.8) 399,783 (15.9) 90,174 (3.6) 65,027 (2.6) 38,954 (1.5) 2,521,148 (100.0)

1,456 2,123,076 (100.0) (100.0)

1,466 1,879,359 (100.0) (100.0)

: ( ) : , ,

30 ( 3-17 ), 2011 30 13.6 93.7% . 5 , , , , , 2011 7.1 42.4% . 30 , , , , . 30 2011 12.5 55.0% .

70 2012

3-17 2011 30 ( : , %) 2009 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 226,280 47,516 74,162 50,643 50,178 35,783 99,264 33,312 28,066 31,973 26,367 12,486 21,380 19,081 25,973 18,219 15,024 8,639 8,888 11,994 8,802 32,016 13,054 8,345 8,034 10,577 6,981 7,784 6,803 11,321 2010 308,634 64,372 78,231 67,704 68,033 52,104 66,076 45,573 35,654 45,118 30,096 23,996 25,339 22,999 25,886 23,073 16,528 14,868 14,764 13,581 11,857 19,858 14,209 11,888 9,859 14,095 8,074 10,429 10,795 11,970 2011 376,256 88,287 87,270 82,795 74,121 73,581 71,298 49,979 43,307 37,456 35,417 29,382 25,551 25,110 19,737 17,575 16,827 16,519 15,071 14,538 14,287 13,945 13,315 13,058 12,026 11,428 11,349 21.9 37.2 11.6 22.3 8.9 41.2 7.9 9.7 21.5 24.5 47.6 16.0 11.1 -3.0 19.4 18.2 14.0 21.6 27.1 2.3 20.2 41.4 -5.5 2009 92,970 60,148 55,003 44,622 66,934 47,245 13,528 25,431 41,455 31,125 27,439 35,791 22,955 42,147 29,035 27,761 15,359 17,388 16,426 18,046 10,087 31,900 29,971 20,878 29,712 18,388 15,010 20,098 17,617 10,360 2010 2011 2.4 47.4 -6.4 3.0 19.9 67.3 21.3 -5.3 0.7 26.3 4.0 28.9 13.7 -0.3 47.1 11.8 35.1 8.6 38.3 2.1 8.2 23.9 16.6 -0.5 7.1 40.0 7.3 20.6 104,759 107,323 64,395 98,452 87,438 71,720 48,187 27,077 35,959 43,200 39,958 31,113 36,102 27,862 47,546 28,381 31,241 20,872 26,610 21,461 25,710 20,012 39,967 27,008 37,681 22,453 18,623 19,534 22,502 20,642 15,674 94,909 81,823 73,877 57,756 45,295 43,624 40,913 40,240 39,303 37,531 35,907 32,265 31,160 30,711 29,739 28,983 27,927 27,678 27,585 24,284 23,073 22,773 22,385 22,107 21,938

86,953 -11.7

38,610 -14.4

35,812 -24.7

19,895 -13.8

14,771 -25.6

27,590 -31.0 25,396 -32.6

61.7 15.3 5.9 -5.2 16.9 22.2 30 (A) (B) (A/B)

30 30 (A) (B) (A/B)

958,948 1,165,661 1,362,760 1,130,379 1,190,226 1,454,361 84.8 97.9 93.7

934,830 1,162,141 1,246,861 2,122,475 1,879,359 2,265,836 44.0 61.8 55.0

: , ,

3 71

2011 20 12.4 74.2%, 20 23.8 94.4% . , , , , , . 3-18 2011 20 ( : , %) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 20 2009 2010 2011

11.5 3.7 15.6 9.2 149.0 52.62009 2010 2011

2009 2010 2011 10

237 125 96 77 3 55 28 35 18 16 0 5 30 24 30 16 8 16 2 14

308 166 113 97 7 83 35 39 35 19 0 5 36 20 36 21 14 16 2 18

343 172 131 106 16 127

763 254 213 94 89 0 40 26 3 45 131 48 13 1 1 14 7 10 31 14

944 1,119 324 273 115 107 0 51 27 9 50 92 60 13 2 2 14 11 16 34 19 344 312 118 115 0 58 41

18.6 526 6.2 129 14.3 117 2.0 7.4 41.2 12.3 49.2 17 86 54 12 9 15 29

636 158 160 19 101 83 16 11 26 31 91 55 23 18 33 8 3 1 32 1

776 172 181 12 99 127 30 6 58 16 56 46 12 42 39 15 6 3 27 11

22.0 8.7 13.3

35.0 1.8 52.6 81.7

28 20.4 35 62 22 1 5 9.4 74.9 18.5 145.9 4.4

153.3 121.4

4 53.5 38 23.7

48.9 38.2 16.0 47.6 128.4 15.9 93.4 94.8 234.1

57 37.7 131 51 14.3 18 2 3 38.2 12.5 3.6 42 17 23 29 2 1 7 29 0

30 15.9 44 41 26 22 17 3 118.3 15.1 24.1 54.6 6.2 75.2

12 15.0 16 19 31 22 43.7 17.3 9.4 15.2

14.0 840.0 3.9 4.5 -

11 40.1

834 1,069 1,242 1,190 1,454 1,673 70.1 73.5 74.2

16.2 1,796 2,165 2,380 15.0 1,879 2,266 2,521 95.6 95.5 94.4

9.9 962 1,096 1,138 11.3 689 811 848 -

: 1. + 2011 2. : , , , , : , ,

72 2012

2. 1) 4 4 2011 3.43 , EU 3.40 1.31, 1.05 5). (20062011) (15.0%) , EU(14.4%), , . 2011 1.05 15.0% . 3-19 4 ( : , %) 2006 2007 2008 2009 2010 2011 (0611)

E U 4(A) (B) (A/B)

190,314 173,611 79,039 52,417 495,381 817,409 60.6

239,855 257,767 95,695 58,026 651,343 1,032,172 63.1

227,797 273,118 80,258 84,198 665,371 1,132,005 58.8

236,862 270,058 95,705 76,711 679,337 1,190,087 57.1

307,980 338,898 113,076 96,622 856,575 1,454,361 58.9

343,313 339,773 130,742 105,502 919,330 1,672,925 55.0 -

12.5 14.4 10.6 15.0 13.2 15.4

: , ,

4 2011 11.19 , EU 6.866), 3.12, 1.18 . 3.6, 9.5 .5) EU 27, . (3.1), (1.65), (1.13), (1.27), (1.05), EU (1.65), (0.35), (0.28) 6) EU (3.44), (0.57), (0.57)

3 73

2006 13.0% , EU 1.2%, 3.5% . 2009 0.94 , 2011 1.18 . 3-20 4 ( : , %) 2006 2007 2008 2009 2010 2011 (0611)

E U 4(A) (B) (A/B)

606,622 647,587 262,856 79,507 1,596,572 1,799,377 88.7

745,158 775,647 300,448 116,232 1,937,486 2,153,921 90.0

738,991 787,753 273,421 112,532 1,912,697 2,123,076 90.1

763,130 608,549 213,004 93,702 1,678,385 1,879,359 89.3

943,828 682,148 273,222 115,417 2,014,614 2,265,836 88.9

1,119,100 686,426 312,157 117,718 2,235,402 2,521,148 88.7 -

13.0 1.2 3.5 8.2 7.0 7.0

: , ,

2) 2006 4.16 2011 7.76 . , . 2006 23.3% 2011 20.5% , 2006 33.7% 2010 44.4% .

74 2012

3-3 : , ,

2011 3 (0.54), (0.47), (0.17) . 3 3 2007 , 2011 37.3% . 10 2.35 68.5% . 2011 3 (0.80), (0.75 ), (0.60). 2011 10 4.19 37.4% .

3 75

3-21 2011 10 ( : , %)2011 2011

1 2 3 4 5 6 7 8 9 10

10

53,655 46,961 27,312 18,598 18,032 15,381 14,545 14,045 13,461 13,288 235,277

15.6 13.7 8.0 5.4 5.3 4.5 4.2 4.1 3.9 3.9 68.5

10

80,001 74,912 60,161 36,703 32,265 30,767 30,177 27,043 23,780 23,122 418,930

7.1 6.7 5.4 3.3 2.9 2.7 2.7 2.4 2.1 2.1 37.4

343,313 100.0

1,119,100 100.0

: , ,

3) EU EU EU 2006 4.74 2007 5.18 2009 , 2011 3.47 . EU 2006 , 2008 , 2009 . EU 2006 21.2% 2011 20.3% , 2006 36.0% 2011 27.2% .

76 2012

3-4 EU : , ,

EU 2011 EU 3 (1.03), (0.31), (0.22) . 3 2011 EU 46.0% . 10 2.20 EU 64.9% . 2011 EU 3 (0.49), (0.35), (0.28) . 2011 10 2.53 EU 36.9% .

3 77

3-22 2011 EU 10 ( : , %)2011 2011

1 2 3 4 5 6 7 8 9 10

10

103,046 30,834 22,425 11,775 10,346 10,033 9,105 8,027 7,744 7,202 220,537

30.3 9.1 6.6 3.5 3.0 3.0 2.7 2.4 2.3 2.1 64.9

10

48,538 35,422 28,085 27,096 25,396 21,245 19,726 17,944 16,207 13,450 253,112

7.1 5.2 4.1 3.9 3.7 3.1 2.9 2.6 2.4 2.0 36.9

339,773 100.0

686,426 100.0

: , ,

4) , , 2007 2009 2.13 2011 3.12 . 2006 1.84 2009 1.17 , 2011 1.81 . 2006 9.7% 2011 7.8% , 2006 14.6% 2011 12.4% .

78 2012

3-5 : , ,

2011 3 (0.36), (0.24), (0.16) . 2011 10 1.03 78.5% . 2011 3 (0.27), (0.22), (0.14) . 10 1.32 42.2% .

3 79

3-23 2011 10 ( : , %) 2011 2011

1 2 3 4 5 6 7 8 9 10

10

35,958 24,529 16,077 9,072 4,397 3,754 2,498 2,482 2,025 1,848 102,640

27.5 18.8 12.3 6.9 3.4 2.9 1.9 1.9 1.5 1.4 78.5

-- 10

26,735 22,039 14,230 12,543 12,474 11,662 9,246 7,796 7,665 7,187 131,577

8.6 7.1 4.6 4.0 4.0 3.7 3.0 2.5 2.5 2.3 42.2

130,742 100.0

312,157 100.0

: , ,

5) 2006 0.27 2007 0.58 2011 0.12 . , 2007 2009 0.94 2011 1.18 . 2006 6.4% 2008 7.4% , 2011 6.3% , 2007 5.4% 2011 4.7% .

80 2012

3-6 : , ,

2011 1 (0.19), 2, 3 (0.16), (0.08) . 10 0.75 71.2% . 2011 3 (0.35), (0.14), (0.09) . 10 0.88, 75.2% .

3 81

3-24 2011 10 ( : , %)2011 2011

1 2 3 4 5 6 7 8 9 10

10

19,039 16,257 8,452 7,207 5,302 4,276 4,177 3,940 3,337 3,126 75,111

18.0 15.4 8.0 6.8 5.0 4.1 4.0 3.7 3.2 3.0 71.2

10

35,050 14,264 9,112 6,361 5,602 5,557 4,142 3,618 2,410 2,403 88,521

29.8 12.1 7.7 5.4 4.8 4.7 3.5 3.1 2.0 2.0 75.2

105,502 100.0

117,718 100.0

: , ,

82 2012

3. 1) . . (, , ) 2011 142 . , . 1. : , (), () 2. : (), 3. : ( ), (), () , 100 , (- ) . 100 , . NICE KISVALUE III7) . (17) (125), (97) (45) 8). , . () 7) IFRS , KISVALUE III K-GAAP 8) // / , KISVALUE /

3 83

. (financial flexibility) . . . () , , . . , . , , , . , . (stock) (flow) . .

84 2012

3-25

= /100-100

, ,

= / 100-100 = / 100-100 = /100

EBIT = (+)/100

. EBIT

= /100 = /100 = /100

. .

= /100

= /100

. ,

: (2011) 2010

3 85

2) 2011 5 5,882 9.6% , 2007 13.0% . . . 2007 2011 14.4% 10.4% . (15.4%) (9.9%) . 3-26 (: , %) 2007 2008 2009 2010 2011 (0711)

(142)

3,425,599 1,234,898 2,190,701 1,884,061 1,541,538 -

4,101,704 19.7 1,560,381 26.4 2,541,323 16.0 2,411,746 28.0 1,689,958 9.6

4,649,725 13.4 1,684,120 7.9 2,965,604 16.7 2,765,159 14.7 1,884,565 11.5

5,097,025 9.6 1,730,781 2.8 3,366,244 13.5 3,004,652 8.7 2,092,373 11.0

5,588,222 9.6 1,834,689 6.0 3,753,533 11.5 3,341,611 11.2 2,246,611 7.4

13.0 10.4 14.4 15.4 9.9 -

: NICE() (KISVALUE)

20 2011 2 6,992 142 48.3% . 1 () 2011 2,675 5.8% , 1 () 36.2% .

86 2012

3-27 (: , %) 2007 2008 2009 2010 2011

1 () 2 3 4 5 6 7 8 9 () () () () () ()

205,308 9,843 184,313 158,411 100,663 105,512 132,639 75,152 74,773 64,979 27,570 62,683 56,118 84,037 63,248 80,178 45,235 83,963 67,810 23,083

216,593 133,998 229,916 159,406 122,701 111,861 147,807 79,845 81,909 80,225 40,341 76,010 71,036 91,049 64,291 81,117 57,957 83,231 70,232 42,564

220,672 189,886 207,380 160,386 150,690 131,861 124,563 86,393 86,929 94,681 67,337 93,472 83,082 100,313 68,731 93,336 72,848 84,687 64,749 43,704

252,847 232,427 236,670 167,371 136,162 138,084 113,888 95,536 122,630 126,629 84,852 95,044 96,580 117,201 89,399 99,493 75,834 92,033 73,456 58,742

267,522 245,857 238,192 168,757 155,946 153,928 131,825 130,141 125,332 124,202 113,236 110,517 107,352 106,304 102,270 100,751 86,837

5.8 5.8 0.6 0.8 14.5 11.5 15.7 36.2 2.2 1.9 33.5 16.3 11.2 9.3 14.4 1.3 14.5

() ()

10 ()9) 11 () 12 () 13 () 14 () 15 () 16 () 17 () 18 () 19 () 20 ()

79,194 14.0 76,039 75,007 3.5 27.7 7.8 9.6

20 (A) (B) 20 (A/B)

1,705,520 2,042,088 2,225,701 2,504,878 2,699,211 3,425,599 4,101,704 4,649,725 5,097,025 5,588,222 49.8 49.8 47.9 49.1 48.3

: NICE() (KISVALUE) 9) 2011

3 87

2011 142 13.3% 6 4,221 . (17.7%) (5.0%) , (16.3%) (12.1%) . 2011 9.6%, 10.7% . , , 2007 11.5% 17.1% . 3-28 (: , %) 2007 2008 2009 2010 2011 (0711)

(142)

3,649,656 1,330,116 2,319,539 2,530,539 1,119,117 -

4,562,361 25.0 1,670,558 25.6 2,891,803 24.7 3,167,900 25.2 1,394,461 24.6

5,179,506 13.5 1,824,176 9.2 3,355,331 16.0 3,668,593 15.8 1,510,914 8.4

5,667,324 9.4 1,957,784 7.3 3,709,541 10.6 4,068,980 10.9 1,598,345 5.8

6,422,107 13.3 2,055,954 5.0 4,366,152 17.7 4,562,930 12.1 1,859,177 16.3

15.2 11.5 17.1 15.9 13.5 -

: NICE() (KISVALUE)

88 2012

142 2011 1 4,712 6.3% . 2007 , 2008 31.5% . (9.8%) . 10) 2011 9.2% 0.1%p , 9.8% 1.4%p . 2007 16.6%, 11.2% , 16.0%, 13.3%. 3-29 (: , %) 2007 2008 2009 2010 2011 (0711)

(142)

830,641 200,980 629,661 618,835 211,806 -

1,092,188 31.5 315,399 56.9 776,789 23.4 829,536 34.0 262,652 24.0

1,279,474 17.1 334,261 6.0 945,213 21.7 968,343 16.7 311,131 18.5

1,384,453 8.2 334,300 0.0 1,050,152 11.1 1,040,776 7.5 343,677 10.5

1,471,234 6.3 307,094 8.1 1,164,140 10.9 1,121,938 7.8 349,296 1.6

15.4 11.2 16.6 16.0 13.3 -

: NICE() (KISVALUE)

10) (2012.10.12), 2011

3 89

2011 22.9% 1.5%p . 2011 17.1%, 28.3% , 2.1%p , 1.6%p . 2011 24.6% 1.0%p , 18.8% 2.7%p . 3-30 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

22.8 15.1 27.1 24.5 18.9 -

23.9 1.2 18.9 3.8 26.9 0.3 26.2 1.7 18.8 0.1

24.7 0.8 18.3 0.6 28.2 1.3 26.4 0.2 20.6 1.8

24.4 0.3 17.1 1.2 28.3 0.1 25.6 0.8 21.5 0.9

22.9 1.5 14.9 2.1 26.7 1.6 24.6 1.0 18.8 2.7

: NICE() (KISVALUE)

90 2012

3) 2011 142 7.9% 0.4%p . 2008 . (2012) 4.5%, 5.6% . (8.0%) (7.8%) . 1.9%p . 10.4% 2.1%p , 4.0% . 5.6% . 3-31 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

9.6 11.7 8.4 11.8 6.8 -

9.4 0.2 12.5 0.8 7.5 0.8 14.3 2.5 2.4 4.4

8.5 0.9 10.7 1.8 7.2 0.3 14.1 0.3 0.3 2.1

8.2 0.2 9.8 0.8 7.4 0.2 12.5 1.5 2.1 1.8

7.9 0.4 8.0 1.9 7.8 0.4 10.4 2.1 4.0 1.9

: NICE() (KISVALUE)

3 91

EBIT 2011 0.4%p EBIT 0.6%p . EBIT . 2011 EBIT 8.2% 6.8% , 9.1% 4.6% . 3-32 EBIT (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

8.8 12.5 6.8 11.2 5.9 -

7.4 1.4 9.9 2.6 5.9 0.9 11.7 0.5 1.2 4.7

8.9 1.5 9.0 0.8 8.8 3.0 12.0 0.3 4.3 3.1

7.9 1.0 9.1 0.1 7.2 1.6 10.6 1.4 3.9 0.4

7.3 0.6 8.2 0.9 6.8 0.4 9.1 1.5 4.6 0.7

: NICE() (KISVALUE)

92 2012

2011 67.4% 0.1%p . . 2007 63.0% 2011 67.7% 5 4.7%p , 2011 67.2% 0.6%p . 2011 63.2% 1.2%p , 73.5% 1.3%p . 3-33 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

65.4 63.0 66.7 62.5 68.8 -

66.4 1.0 63.5 0.5 68.1 1.4 61.4 1.2 73.5 4.7

67.5 1.1 65.9 2.4 68.4 0.3 61.6 0.3 76.1 2.6

67.3 0.2 66.2 0.3 67.8 0.6 62.0 0.4 74.9 1.3

67.4 0.1 67.7 1.5 67.2 0.6 63.2 1.2 73.5 1.3

: NICE() (KISVALUE)

3 93

2011 24.8% , 0.3%p . 2011 0.4%p 2010 0.2% . 2008 24.3% 2011 26.3% 2%p , 2007 24.3% 2011 22.5% 1.8%p . 3-34 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

25.1 25.3 24.9 25.6 24.3 -

24.2 0.8 24.0 1.3 24.3 0.6 24.3 1.3 24.1 0.3

24.0 0.2 23.4 0.6 24.3 0.0 24.3 0.0 23.6 0.5

24.5 0.5 23.9 0.5 24.8 0.4 25.5 1.2 23.1 0.5

24.8 0.3 24.4 0.4 25.0 0.2 26.3 0.9 22.5 0.6

: NICE() (KISVALUE)

94 2012

4) 142 2011 90.1% 4.1%p . 2008 2011 . 2011 152.7%, 109.2% . , (69.3%) (101.8%) 32.5%p . , 2011 4.2%p . , 2011 72.0% 109.2% . 2011 156.8%, 2008 . 3-35 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

94.7 68.8 113.5 78.9 143.5 -

105.3 10.6 80.7 11.9 122.8 9.3 82.3 3.5 187.5 43.9

93.9 11.4 70.6 10.1 109.4 13.4 73.5 8.9 171.6 15.9

86.0 7.9 67.3 3.3 97.7 11.7 66.6 6.8 164.4 7.2

90.1 4.1 69.3 1.9 101.8 4.2 72.0 5.3 156.8 7.6

: NICE() (KISVALUE)

3 95

2011 52.6% 1.2%p . 2007 , 2011 . 39.6% . , (59.1%) (49.5%) , , 2011 58.2% 47.8% . 3-36 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

51.4 59.2 46.8 55.9 41.1 -

48.7 2.6 55.3 3.9 44.9 2.0 54.8 1.1 34.8 6.3

51.6 2.9 58.6 3.3 47.7 2.9 57.7 2.8 36.8 2.0

53.8 2.2 59.8 1.2 50.6 2.8 60.0 2.4 37.8 1.0

52.6 1.2 59.1 0.7 49.5 1.0 58.2 1.9 38.9 1.1

: NICE() (KISVALUE)

96 2012

2008 2009 . 2011 157.3% 4.1%p . 2011 162.4%, 155.2%. 172.2% 14.0%p , 134.8% 8.3%p . . 3-37 (: %, %p) 2007 2008 2009 2010 2011

(142) (%p) (%p) (%p) (%p) (%p)

158.4 177.7 149.3 177.7 133.8 -

145.2 13.2 157.8 19.9 138.7 10.6 163.1 14.7 121.8 12.1

153.9 8.6 166.6 8.8 147.8 9.1 171.8 8.8 128.2 6.4

161.4 7.5 170.7 4.2 157.0 9.2 186.2 14.4 126.5 1.7

157.3 4.1 162.4 8.3 155.2 1.8 172.2 14.0 134.8 8.3

: NICE() (KISVALUE)

4 97

4

1. 1) , . 2011 2,988 (Espicom, 2012), 2010 9.7% , 2006 7.9% . 85% , , , 2011 3 9,000 11.5% , . , . , . , .

98 2012

2) 2011 10 . . (annual report) GlobalData Medical e-Track . 2011 . . , . , , , , . . 4-1 4

CTMRI , , (, ) , , (, ) , , () (, ) CT, X-ray ,

4 99

2. 4 10 2011 /, /, / , . 1 Johnson&Johnson(Medical Devices and Diagnostics: MD&D) 3 , / 158.8 (61.6%) . / GE Healthcare, Siemens Healthcare, Philips Healthcare 162.8, 160, 123.2 . Roche Diagnostics 2011 109.8 / . / Johnson&Johnson(MD&D) ETHICON ENDOSURGERY(50.8), Medtronic Inc.(42.8), Covidien plc(MD)(42.6), Stryker(31.6) . / Johnson&Johnson(MD&D), Medtronic Inc.(119 ), Baxter International Inc.(78), Boston Scientific(64.4) . 10 / , DENTSPLY International Inc., Zimmer Holdings, Straumann, Nobel Biocare

100 2012

4-1 10 4

. 1 Johnson&Johnson (MD&D) 3 , , , , , . Medtronic, Inc. , , , , . GE Healthcare, Siemens Healthcare, Philips Healthcare CT, MRI, , Healthcare IT .

4 101

4-2 10 4 ( : %)4 (2011) / / / /

1

Johnson&Joh nson (MD&D) GE Healthcare Siemens Healthcare Medtronic, Inc. Philips Healthcare Roche Diagnostics Covidien plc(MD) Stryker Corporation Baxter International Inc.(MP) Boston Scientific Corporation

18.7

19.7

61.6

-

( ) , , , , , , CT, MRI, PET, , PACS, , CT, MRI, X-ray, , , , , , , X-ray, CT, MRI, , PACS, () , , , , , , , , , , , ,

2 3 4 5 6 7 8

90.1 91.8 100.0 100.0 8.9 -

9.9 8.2 26.5 44.4 38.0

73.5 46.7 62.0

-

9

-

-

100.0

-

10

-

15.6

84.4

-

10 . / (), (), (PACS) , / . / (, ) ( ) , / (

102 2012

), ( CT, X-ray), ( ) . 4-3 10 ( : %)

1 2 3 4 5 6 7 8 9 10

() () () () () () () () () ()

, ( X-ray, CT) (, , ) , , ( ) , , ,

/ / / / / / / / / /

3. 1) 10 2011 6.8% , 2007 5.1% . 10 2011 1,341.2 2007 .

4 103

4-2 10

10 49% , Covidien plc(MD), Stryker, Roche Diagnostics 8% .

4-3 10 (20072011)

104 2012

4-4 10 ( : , %) 2007 2008 2009 2010 2011 10 CAGR (0711)

1 2 3 4 5 6 7 8 9 10

Johnson&Johnson (MD&D) GE Healthcare Siemens Healthcare Medtronic, Inc. Philips Healthcare Roche Diagnostics Covidien plc(MD) Stryker Corp. Baxter International Inc.(MP) Boston Scientific Corp.

217.4 170.0 135.0 131.9 90.9 77.9 69.3 60.0 64.7 83.6 1,100.6

231.3 173.9 164.3 142.6 112.5 89.2 77.0 67.2 68.7 80.5 1,207.1

235.7 160.2 166.4 153.9 109.4 92.7 78.1 67.2 69.2 81.9 1,214.7

246.0 169.0 164.1 155.1 114.1 100.3 84.4 73.2 71.6 78.1 1,255.8

257.8 180.8 174.2 161.8 123.2 109.8 96.1 83.1 78.0 76.2 1,341.2

4.8 7.0 6.2 4.4 8.0 9.5 13.9 13.5 9.0 -2.4 6.8

4.4 1.6 6.6 5.3 7.9 9.0 8.5 8.5 4.8 -2.3 5.1

2) 10 2011 18.6%, 1028% . 2011 Covidien plc(MD)(27.8%), Medtronic, Inc.(25.6%), Roche Diagnostics(22.4%) . Top 10 : 10

4 105

4-4 10 (20102011)

2011 10 10 . 10 18.6% 10 11.1% 7.5%p . 4-5 10 (2011) (%)

Top 10 Johnson&Johnson(MD&D) Siemens Healthcare Medtronic, Inc. Top 10 () () ()

18.6 20.4 10.7 25.6 11.1 6.2 16.0 12.8

* Top 10 : 7.5%p /, /, / /, /, /, /

/ / /

106 2012

3) 2011 10 7.5% . 2011 Johnson&Johnson(MD&D) 17.5 , Siemens Healthcare(16.4), Medtronic, Inc.(14.9) , 2011 Boston Scientific Corp.(11.7%), Siemens Healthcare(9.4%), Medtronic, Inc.(9.2%) . 4-6 10 ( : , %, %p) 2010 2011 2010 2011

1 2 3 4 5 6 7 8 9 10

Johnson&Johnson (MD&D) GE Healthcare Siemens Healthcare Medtronic, Inc. Philips Healthcare Roche Diagnostics Covidien plc(MD) Stryker Corporation Baxter International Inc.(MP) Boston Scientific Corporation

18.0 9.9 14.8 14.7 9.3 9.2 3.6 3.9 5.1 9.4 98.0

17.5 10.4 16.4 14.9 10.3 8.0 4.6 4.6 5.3 9.0 100.9

2.9 4.9 10.9 1.2 11.2 13.6 27.1 17.3 4.2 4.7 3.0

7.3 5.9 9.0 9.5 8.1 9.2 4.3 5.4 7.1 12.0 7.8

6.8 5.7 9.4 9.2 8.4 7.3 4.8 5.6 6.8 11.7 7.5

0.5 0.1 0.4 0.3 0.2 1.9 0.5 0.2 0.3 0.3 0.3

10 10 , . Johnson&Johnson (MD&D) 2011 17.5 (0.26) 67, 10 (0.65) 27 . , 10 9.1% 10 7.5% 1.5%p . Top 10 : 10

4 107

4-7 10 (2011)( : , %)

Top 10 Johnson&Johnson(MD&D) Top 10 ()

100.9 17.5 0.65 0.26

7.5 6.8 9.1 11.5 * 67, Top 10 27 * Top 10 1.5%p

4. 10 /, /, / , . 10 2011 6.8% , 5.1% . 10 2011 1,341.2 2009 . 10 7.5%p , . 2011 18.6%, 10 11.1% . Johnson&Johnson(MD&D) 17.5 (2011) 67, 10 27 . 10 1.5%p . 2007 , . , , .

108 2012

5

. , , . , . . 2011 2,988 , 4.3 , 8( ) . , . , , . , . , . , 8.5(9,399 ) .

5 109

. 2007 3.2 13.0% 2011 5.6 . , , 2007 . , , , . 67% , MRI, CT 95% . . , . 7.5%p, 10 1.5%p . 2007 , . , , .

111

2012-4(2012. 9.13). . (2010.11). 2015 10 . (2010.11). EU FTA . . dart.fss.or.kr. .[ 2010.11.28] [ 10326, 2010. 5.27, ]. (2012). . , (2006). 2015 R&D. . . . 2012-45(2012. 7.10). . 2012-117(2012.11.00). . . . . 2010-71(2010. 4. 1). . (2009). (). (2006).. (2012). 2011 . (2011). 2011 . Espicom(2012).. The World Medical Markets Fact Book 2011. Johnson and Johnson . (annual reports). NICE. www.nicecredit.com.

115

1 ( : , , %)2009 2010 2011 2010

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

US DE JP RU CN IN IR ID BR IT TR AR TW FR TH VN MX MY GB HK UA SA

236,862,276 125,069,021 95,705,121 54,523,425 76,711,423 18,489,712 20,221,038 24,351,668 29,639,730 35,232,180 51,764,613 14,235,269 29,598,317 28,427,123 15,701,928 15,421,087 21,867,093 8,074,427 15,669,300 9,057,585 15,289,732 8,064,214

307,980,139 165,635,491 113,075,645 83,453,868 96,621,725 35,495,574 31,716,315 20,109,321 35,795,356 38,703,962 35,725,200 24,894,375 35,769,246 34,777,105 21,345,498 16,697,759 28,104,872 14,211,096 18,537,635 15,926,726 15,874,416 9,482,264

221 125 151 117 168 119 142 139 55 115 145 34 103 76 117 109 58 124 79 112 44 104

343,313,458 171,844,863 130,741,777 127,311,833 105,501,638 62,066,973 48,365,969 43,889,938 41,191,813 35,054,038 32,182,720 30,984,397 30,078,505 27,668,876 26,486,594 25,383,551 22,054,234 21,968,216 21,961,701 17,391,106 17,373,406 16,687,468

20.5 10.3 7.8 7.6 6.3 3.7 2.9 2.6 2.5 2.1 1.9 1.9 1.8 1.7 1.6 1.5 1.3 1.3 1.3 1.0 1.0 1.0

11.5 3.7 15.6 52.6 9.2 74.9 52.5 118.3 15.1 9.4 9.9 24.5 15.9 20.4 24.1 52.0 21.5 54.6 18.5 9.2 9.4 76.0

116 2012

2009

2010

2011 2010

23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48

SG ES CH AU PH PE PT BE PL VE EG KZ ZA RO CZ NO CA AE NL KW SY CL LT PK CO LB

16,121,116 12,564,062 2,963,286 13,844,939 7,772,414 10,576,989 1,815,267 7,223,247 8,630,950 7,160,666 5,343,175 12,127,522 6,122,046 2,245,983 6,431,943 2,655,034 2,197,068 3,738,656 5,228,346 1,606,770 5,417,155 8,766,225 3,192,703 2,325,315 6,172,180 3,103,914

15,681,978 15,392,319 6,506,554 18,142,296 7,346,479 6,689,107 9,688,120 7,857,113 9,099,706 7,017,485 5,888,921 5,277,694 4,811,858 7,707,945 4,909,407 5,759,511 3,471,484 5,050,540 5,029,421 4,870,559 5,214,119 3,762,851 4,077,087 2,723,075 4,439,217 3,771,851

89 74 47 76 86 45 28 33 72 26 59 24 46 44 42 21 44 76 37 35 47 50 32 66 40 43

16,656,401 16,233,697 16,201,924 10,867,128 9,742,480 9,586,707 8,807,948 8,507,519 7,734,917 7,654,953 7,525,410 7,384,097 7,131,447 7,019,964 6,993,310 6,987,098 6,699,553 6,058,706 5,251,728 5,174,895 4,905,734 4,647,220 4,532,436 4,299,313 4,277,927 3,119,783

1.0 1.0 1.0 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2

6.2 5.5 149.0 40.1 32.6 43.3 9.1 8.3 15.0 9.1 27.8 39.9 48.2 8.9 42.4 21.3 93.0 20.0 4.4 6.2 5.9 23.5 11.2 57.9 3.6 17.3

117

2009

2010

2011 2010

49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

SE FI MA BD GR EC IQ DZ KH AZ IL HU AT DK SD MN JO UZ TN NG RS PA GE HR LK BG

1,910,926 2,225,293 1,590,106 2,292,545 3,452,863 1,528,426 707,133 5,714,718 485,614 1,948,194 3,366,684 775,054 5,780,145 1,285,497 666,535 748,458 1,585,929 1,083,601 526,127 407,072 98,949 1,087,083 400,221 1,226,220 554,397 1,482,257

1,770,270 2,505,740 2,368,650 2,407,265 3,563,099 3,707,523 2,757,088 4,894,495 1,998,471 2,126,478 3,086,331 1,894,522 3,298,537 1,863,112 1,507,173 1,108,334 1,470,028 1,504,817 833,503 703,334 918,672 1,314,897 340,029 1,170,857 850,779 238,765

25 25 25 34 59 23 31 14 19 11 44 33 25 14 16 37 30 14 16 20 8 11 11 12 31 29

3,102,205 3,034,179 2,957,586 2,932,998 2,902,042 2,827,112 2,635,769 2,620,866 2,616,090 2,277,425 2,230,729 2,120,270 2,071,675 1,837,461 1,737,694 1,568,458 1,490,148 1,270,509 1,164,270 1,122,331 961,635 930,071 867,902 830,329 741,799 738,253

0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0

75.2 21.1 24.9 21.8 18.6 23.7 4.4 46.5 30.9 7.1 27.7 11.9 37.2 1.4 15.3 41.5 1.4 15.6 39.7 59.6 4.7 29.3 155.2 29.1 12.8 209.2

118 2012

2009

2010

2011 2010

75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100

NP AM DO IE AL MM BZ KG NZ GD CR UY YE IO AF SK SI GU KE BL ZZ PY AO BO PS TK

387,503 125,160 45,987 227,147 588,803 139,885 410,811 133,103 359,076 257,523 481,761 913,489 49,687 22,394 156,990 759,586 910,073 300,511 28,694 2,523,153 289,000 162,915 137,315

694,024 389,723 251,583 269,216 768,405 136,430 443,477 625,036 701,269 439,586 610,712 1,307,118 82,302 439,695 112,048 859,854 15,479 966,956 1,288,638 752,797 524,449 538,899 733,240 736,381 142,624

6 8 15 10 9 10 1 11 20 1 8 7 15 10 8 12 17 2 15 1 8 9 3 5 10 3

726,008 671,648 665,123 662,125 624,833 611,250 606,124 587,706 586,966 583,499 582,566 582,516 542,327 540,168 529,213 503,969 476,455 470,103 463,303 455,345 452,021 444,777 439,851 433,607 414,576 404,857

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

4.6 72.3 164.4 145.9 18.7 348.0 36.7 6.0 16.3 n.a 32.5 4.6 58.5 556.3 20.4 349.8 44.6 2,937.0 52.1 64.7 40.0 15.2 18.4 40.9 43.7 183.9

119

2009

2010

2011 2010

101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126

CU QA MK BH HN GT ET EE GH MD LV SN OM MU TZ SV IS LU CG CY LA LY BY TJ BA TM

455,485 851,620 508,157 199,828 973,780 454,195 13,479,388 846 243,430 99,490 124,562 62,960 107,363 48,722 84,839 16,964 36,349 25,321 108,194 16,502 569,780 399,293 35,772 722,446 -

232,083 342,011 311,999 155,684 949,566 4,172,883 92,438 250,411 6,829 295,614 151,931 2,851 138,406 123,447 134,585 90,148 21,919 366,957 5,875 335,699 149,305 658,278 281,706 86,313 88,702 26,138

4 11 7 16 8 9 3 10 3 9 7 1 8 5 6 4 3 3 1 10 5 6 5 2 3 2

392,163 361,519 355,157 349,759 340,830 307,532 278,472 271,351 247,846 229,992 203,390 169,627 166,317 149,093 148,777 131,989 130,472 115,277 115,250 108,179 107,006 103,452 96,261 82,423 78,719 78,260

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

69.0 5.7 13.8 124.7 64.1 92.6 201.3 8.4 3,529.3 22.2 33.9 5,849.7 20.2 20.8 10.5 46.4 495.2 68.6 1,861.7 67.8 28.3 84.3 65.8 4.5 11.3 199.4

120 2012

2009

2010

2011 2010

127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152

AG PR CM MO NI AN LR PG UG RW AW MG GY JM FJ MT MV SZ BN GA FM AD ZW MR TG MZ

56,451 193,314 20,063 56,925 418,674 47,519 5,600 50,752 2,330 617,026 10,950 3,600 780

58,420 15,885 2,000 67,563 9,504 120,310 7,000 66,147 8,434 5,421 15,233 13,569 2,241 42,435 30,819 17,450 53,280 102,520 -

1 3 1 2 5 1 1 1 2 3 1 2 1 1 1 4 1 1 1 1 1 2 1 1 1 1

77,172 68,079 58,145 51,953 41,265 39,000 38,872 29,900 27,092 23,289 20,569 18,687 17,303 16,063 15,500 15,125 14,755 11,229 10,286 10,000 7,500 7,080 6,500 5,280 5,000 4,800

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

32.1 328.6 2,807.3 23.1 334.2 67.6 455.3 54.8 221.2 n.a n.a 244.7 13.6 n.a 14.2 574.9 n.a 73.5 66.6 n.a 57.0 n.a 87.8 n.a 95.1 n.a

121

2009

2010

2011 2010

153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174

NE CI HT BJ CV MS BV GN KY ML NC GQ CF BF BT CS DM GM KP NA SR YU

fot

5,000 9,050 10,222 9,038 771 300 16,165 10,000 5,200 5,078 247,520 76,000 348,260 1,640 569,426 1,190,086,806

32,200 29,570 10,222 9,038 6,386 3,378 3,137 2,500 960 420 1,454,360,815

2 2 1 1 -

3,470 3,010 1,750 800 1,672,924,698

0.0 0.0 0.0 0.0 100.0

n.a n.a n.a 97.5 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 n.a n.a n.a n.a n.a n.a n.a n.a n.a 15.0

122 2012

2 ( : , , %)2009 2010 2011 2010

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

US DE JP CN CH FR IE NL IT GB SE IL AU AT SG BE TW MY DK TH DO FI VN CA LI

763,129,952 253,915,583 213,003,996 93,702,319 88,734,775 40,043,936 131,463,223 47,622,368 26,090,590 45,108,191 30,651,236 16,057,445 13,556,560 11,072,012 9,617,881 1,318,556 12,556,151 7,179,849 9,259,542 13,554,720 7,278,403 5,108,005 1,189,649 5,425,101 4,063,471

943,827,992 323,660,529 273,221,601 115,417,058 107,318,164 51,202,354 91,599,929 59,882,051 27,493,175 49,581,632 33,747,275 15,630,728 19,357,733 12,539,678 16,482,552 9,806,677 13,223,373 11,187,535 9,984,008 13,644,629 7,350,914 6,255,154 4,258,413 4,687,412 5,125,163

537 329 259 330 108 104 28 34 126 110 53 67 30 23 25 21 105 43 41 23 4 23 8 47 3

1,119,100,253 343,608,108 312,157,489 117,718,367 115,221,507 57,520,424 57,084,003 51,318,582 41,026,004 37,829,751 30,591,378 24,218,964 22,292,657 19,363,717 19,330,804 18,440,139 18,270,777 16,078,519 12,412,177 11,595,801 8,689,560 7,840,480 7,398,957 5,403,601 5,295,231

44.4 13.6 12.4 4.7 4.6 2.3 2.3 2.0 1.6 1.5 1.2 1.0 0.9 0.8 0.8 0.7 0.7 0.6 0.5 0.5 0.3 0.3 0.3 0.2 0.2

18.6 6.2 14.3 2.0 7.4 12.3 37.7 14.3 49.2 23.7 9.4 54.9 15.2 54.4 17.3 88.0 38.2 43.7 24.3 15.0 18.2 25.3 73.7 15.3 3.3

123

2009

2010

2011 2010

26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51

IN NZ ES PH NO MX BR HK HU PK ID LT SI PR CZ TR SC AR RU ZA LK RO CR PL PT AN

3,430,722 945,120 2,582,072 2,727,572 2,962,737 3,173,418 1,020,438 139,478 867,640 2,371,772 1,265,988 193,476 204,360 349,507 1,303,441 76,565 136,273 467,802 386,602 46,390 286,740 1,345,191 1,535,511 303,203 147,783

9,451,637 2,212,076 2,611,403 4,008,753 3,680,988 3,901,900 2,426,293 49,506 1,653,843 2,207,866 1,754,598 279,631 726,082 527,977 557,289 560,199 190,874 309,302 180,801 319,802 280,860 486,620 661,363 70,298 100 72,678

31 7 23 7 12 10 11 4 9 47 5 2 2 5 8 8 1 5 9 2 1 1 2 8 1 3

4,394,819 4,267,438 4,259,138 4,168,168 3,896,718 3,211,309 2,512,886 2,348,916 2,342,251 2,324,467 1,974,523 881,321 863,885 683,164 572,921 435,095 321,882 256,353 255,226 203,117 196,243 187,552 172,198 136,183 108,744 95,435

0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

53.5 92.9 63.1 4.0 5.9 17.7 3.6 4,644.7 41.6 5.3 12.5 215.2 19.0 29.4 2.8 22.3 68.6 17.1 41.2 36.5 30.1 61.5 74.0 93.7 108,644.0 31.3

124 2012

2009

2010

2011 2010

52 53 54 55 56 57 58 59 60 61

SM MU IS MT SZ BQ IR CO GR GE

605 33,395 139,500 96,108 38,575 5,737 70,541 1,152 1,879,358,928

21,135 85,994 9,691 5,533 44,554 140 2,265,835,515

2 1 1 2 1 1 1 -

90,082 82,876 46,103 39,594 7,981 4,239 2,521,148,077

0.0 0.0 0.0 0.0 0.0 0.0 100.0

326.2 3.6 n.a 308.6 44.2 90.5 n.a n.a 100.0 n.a 11.3

2012 / / / 2012 12 31 / : 02) 313-7593KOREA HEALTH INDUSTRY DEVELOPMENT INSTITUTE

www.khidi.or.kr

126 2012